US20040015124A1 - Fluid delivery system having a syringe interface module separate from but in communicaiton with a control unit - Google Patents

Fluid delivery system having a syringe interface module separate from but in communicaiton with a control unit Download PDF

Info

Publication number
US20040015124A1
US20040015124A1 US10/619,265 US61926503A US2004015124A1 US 20040015124 A1 US20040015124 A1 US 20040015124A1 US 61926503 A US61926503 A US 61926503A US 2004015124 A1 US2004015124 A1 US 2004015124A1
Authority
US
United States
Prior art keywords
delivery system
fluid delivery
syringe
control unit
syringe interface
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/619,265
Inventor
Francis Sciulli
David Griffiths
William Nolan
Richard Critchlow
Salvatore Dedola
Michael Spohn
Frank Lazzaro
Thomas Joyce
John Gardner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Medical Care Inc
Original Assignee
Medrad Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medrad Inc filed Critical Medrad Inc
Priority to US10/619,265 priority Critical patent/US20040015124A1/en
Assigned to MEDRAD, INC. reassignment MEDRAD, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GARDNER, JOHN R., CRITCHLOW, RICHARD G., DEDOLA, SALVATORE J., GRIFFITHS, DAVID M., JOYCE, THOMAS P., LAZZARO, FRANK A., NOLAN, WILLIAM J., JR., SCIULLI, FRANICS J., SPOHN, MICHAEL A.
Publication of US20040015124A1 publication Critical patent/US20040015124A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/145Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
    • A61M5/1452Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
    • A61M5/14546Front-loading type injectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/16831Monitoring, detecting, signalling or eliminating infusion flow anomalies
    • A61M5/16854Monitoring, detecting, signalling or eliminating infusion flow anomalies by monitoring line pressure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/70General characteristics of the apparatus with testing or calibration facilities
    • A61M2205/702General characteristics of the apparatus with testing or calibration facilities automatically during use
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/007Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests for contrast media
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/1413Modular systems comprising interconnecting elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/145Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
    • A61M5/1452Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
    • A61M5/14566Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons with a replaceable reservoir for receiving a piston rod of the pump

Definitions

  • the present invention relates generally to injectors, injector systems and control of injectors and injector systems, and, especially, to injectors, injector systems and injector control for use in medical procedures in which a fluid is injected into a patient.
  • a powered injector should be carefully controlled. For example, it is desirable not to exceed a certain fluid pressure during an injection procedure. In addition to potential hazards to the patient (for example, vessel damage) and potential degradation of the diagnostic and/or therapeutic utility of the injection fluid, excessive pressure can lead to equipment failure. For example, because of the potential of cross-contamination between patients, the syringe and tubing used to carry fluid to a patient are typically changed on a per-patient basis. Such disposable syringes and other fluid path components (sometimes referred to collectively as a “disposable set”) are typically fabricated from plastics of various burst strengths. If the injector causes pressure in the fluid path to rise above the burst strength of a disposable fluid path element, the fluid path element will fail.
  • the present invention provides an injector for use in injecting a fluid in a medical injection procedure.
  • the injector includes a drive mechanism to pressurize the fluid; a sensor to measure a variable that is proportional to fluid pressure (that is, a direct or indirect measurement of fluid pressure); and a pressure monitor (for example, including hardwired circuitry and/or software) in communication with the sensor and the drive mechanism to stop the injection procedure when the sensor measures a value of the variable that corresponds to a pressure hazard limit.
  • the pressure monitor further limits power input to the drive mechanism to a power limit once the variable reaches a value that corresponds to a power limiting pressure that is below the pressure hazard limit. In this manner, the pressure hazard limit should never be reached. If, however, the power limiting feature fails, the injector terminates the injection procedure once the pressure hazard limit is reached.
  • the drive mechanism may, for example, receive power from a motor.
  • the sensor can, for example, measure motor current.
  • the pressure monitor can limit the motor current to a value corresponding to the power limiting pressure.
  • the power limit is typically predetermined or preset for the injector in this embodiment.
  • the senor measures force exerted upon a component of the drive mechanism or an injector component in connection with the drive mechanism.
  • the sensor can measure force upon any component of the injector that bears a load proportional to the fluid pressure.
  • a force sensor for example, a strain gauge
  • pressure transducer is used to measure fluid pressure, setting of the power limit during injector use and periodic auto-recalibration are facilitated.
  • the present invention provides an injector for use in injecting a fluid in a medical injection procedure including: a drive mechanism to pressurize the fluid; a sensor to measure a variable that is proportional to fluid pressure;
  • a pressure monitor in communication with the sensor and the drive mechanism to limit power input to the drive mechanism to a power limit once the variable reaches a value that corresponds to a power limiting pressure.
  • the present invention provides an injector system for use in injecting a fluid in a medical injection procedure including a drive mechanism to pressurize the fluid and a control mechanism to control flow rate of the fluid and volume of the fluid injected.
  • the injector further includes a sensor including a force transducer providing a measure of fluid pressure and a pressure monitor in communication with the sensor and the drive mechanism to stop the injection procedure when the sensor measures a pressure corresponding to a pressure hazard limit.
  • the pressure monitor also preferably limits power input to the drive mechanism to a power limit when the sensor measures a pressure corresponding to a power limiting pressure. As discussed above, the power limiting pressure is less that the pressure hazard limit.
  • the present invention provides an injector system for use in injecting a fluid in a medical injection procedure including a drive mechanism to pressurize the fluid and a control mechanism to control flow rate of the fluid and volume of the fluid injected (typically on the basis of flow rate and volume setting input by the user of the injector using a data entry mechanism as known in the art).
  • the injector also includes a safety system including a sensor (for example, a force transducer) to provide a measure of fluid pressure.
  • the safety system also includes a pressure monitor in communication with the sensor and the drive mechanism. The pressure monitor is adapted to override settings of the control mechanism and stop the injection procedure when the sensor measures a pressure corresponding to a pressure hazard limit.
  • the pressure monitor is adapted to override settings of the control mechanism to limit power input to the drive mechanism to a power limit when the sensor measures a pressure corresponding to a power limiting pressure, the power limiting pressure being below the pressure hazard limit.
  • the power limit is preferably the power being supplied to the drive mechanism when the power limiting pressure is measures.
  • the present invention provides a method of controlling an injector used in a medical injection procedure.
  • the method includes measuring a variable that is proportional to fluid pressure, and limiting power input to a drive mechanism of the injector to a power limit once the variable reaches a value that corresponds to a power limiting pressure.
  • the method may also include terminating the injection procedure if the value of the variable corresponds to a pressure hazard limit, the pressure hazard limit being greater than the power limiting pressure.
  • the present invention provides an injector for use with a syringe having a plunger disposed therein to inject a fluid in a medical procedure.
  • the injector includes a control unit including a control unit housing and control circuitry disposed within the control unit housing, and at least one syringe interface module including a module housing, at least one syringe interface on the module housing that is adapted to connect the syringe to the module housing and at least one drive member within the module housing to control motion of the plunger, the module housing being moveable relative to the control unit housing.
  • the module housing is rotatable relative to the control unit housing. In another embodiment the module housing is physically detached from the control unit housing.
  • the present invention provides a system for performing a medical imaging procedure including an injector, the injector including a portable remote control panel, an imaging apparatus, and an attachment member in the vicinity of (or attached to) the imaging apparatus.
  • the attachment member is adapted to attach or support the remote control panel in the vicinity of the imaging apparatus to facilitate generally simultaneous access by the operator to both the remote control panel and the imaging apparatus while performing the medical imaging procedure.
  • FIG. 1A illustrates a schematic representation of one embodiment of a fluid delivery system for use in the present invention.
  • FIG. 1B illustrates an embodiment of pressure limiting through limiting motor current.
  • FIG. 2 illustrates the relationship between motor current and system pressure for an injector.
  • FIG. 3A illustrates a predicted maximum pressure distribution
  • FIG. 3B illustrates an operating range over which certain injectors having a set power limit may operate.
  • FIG. 3C illustrates a schematic representation of the embodiment of FIG. 1A including a monitoring system for various conditions.
  • FIG. 4A illustrates a schematic representation of an embodiment of an injector system of the present invention in which a force sensor or transducer is used to measure pressure.
  • FIG. 4B illustrates a schematic representation of an embodiment of the injector system of FIG. 4A.
  • FIG. 4C illustrates a power limited operating range of the injector systems of FIGS. 4A and 4B.
  • FIG. 5A illustrates a cross-sectional view of an embodiment of a syringe interface module in which fluid pressure is measured via a transducer/sensor.
  • FIG. 5B illustrates a front plan view of a rear plate including strain gauges.
  • FIG. 5C illustrates a rear plan view of the rear plate of FIGS. 5B including strain gauges.
  • FIGS. 6A through 6C illustrate another embodiment of an injector of the present invention in which an syringe interface module is movable/rotatable relative to a control unit of the injector.
  • FIG. 6D illustrates an embodiment of a system of the present invention in which an imaging unit is provided with a connector for attaching an injector remote control panel to the imaging unit.
  • FIG. 7 illustrates an embodiment of an injector comprising two syringe interface modules rotatably connected to a control unit housing.
  • FIG. 8 illustrates an embodiment of an injector comprising a syringe interface module rotatably connected to a control unit housing and having two syringe interfaces.
  • FIG. 9 illustrates an embodiment of an injector comprising a syringe interface module physically disconnected from a control unit housing.
  • FIG. 1A illustrates several components of a fluid delivery system for use in the present invention.
  • the fluid delivery system includes an operator interface connected to a controller, which may include a computer (including, for example, a processing unit 10 and a memory 20 ), that is supplied by a power source.
  • the power source may, for example, include a battery or other electrical power supply.
  • the controller sends activation energy to the actuator, which powers a drive mechanism.
  • the drive mechanism is connected to a fluid chamber such as a syringe (see, for example, FIG. 5A) that contains a volume of injection fluid to be pressurized.
  • the fluid chamber connects to the patient through a fluid path.
  • the fluid path may, for example, include sterile tubing that connects to the patient.
  • the control systems of the injectors of the present invention preferably treat pressure as a hazard, rather than as a variable to be controlled.
  • a pressure hazard limit can be set as a trip point in the present invention.
  • the performance of the injector is further limited in a manner to ensure that the user is not inconvenienced by continual shutdowns during normal operations.
  • the power delivered to the drive mechanism is limited in a manner so that the pressure hazard limit or upper hazard level is not reached.
  • the actuator includes a DC brush type motor.
  • the power delivered to the drive mechanism can be limited by presetting a clamp on the maximum current that can be delivered to the motor.
  • the maximum current corresponds to a fluid pressure (the “power limiting pressure”) that is below the pressure hazard limit.
  • the injector With the drive power limited to the set value (that is, the power limit), the injector will not be able to generate enough pressure to cause a hazard (that is, to reach the pressure hazard limit). If pressure in the system rises to the point where the injector enters a state of power limited operation (that is, the current has reached the set maximum current), operation of the injector will be smooth rather than oscillatory (as experienced with currently available injectors).
  • injectors adjust the motor current based on both a sampled current and an actual, estimated or programmed flow rate of the delivery system. Unlike currently available injectors, the injector of the present invention is not tracking the operation of a compliant system, but is simply limiting current delivered to the motor to the maximum current. The injector control of the present invention thus results in improved smoothness of flow rate when the injector is in a limiting state of operation.
  • Motor current can be limited through electronic circuitry (as known in the art) that samples the motor current, compares the magnitude to the threshold set level and limits the applied current to the device.
  • Motor current can, for example, be controlled by a pulse width modulation (PWM) type drive with a current limit comparator.
  • PWM pulse width modulation
  • the terms “pulse width modulation” or “PWM” refer to an encoding scheme in which a quantity is encoded by the proportion of a fixed time period in which a signal is held active. The proportion is referred to as the “duty cycle,” and is often referred to in percent.
  • the PWM cycle in progress is preferably prematurely terminated and held off for a fixed time period, reducing current to the motor until the next cycle.
  • control process of the present invention limits output fluid power (flow rate ⁇ pressure) by limiting electrical input power (current ⁇ voltage) to the motor by limiting the maximum value of motor current.
  • the relationship between motor current and pressure is illustrated in FIG. 2.
  • the limit threshold for motor current was fixed at a single value for the injector and was not flow rate dependent.
  • the variation in the predicted pressure was found to be small enough to allow all injector systems of a particular type to be constructed with such a fixed limit, thereby avoiding the need for pressure calibration.
  • FIG. 3A illustrates a predicted maximum pressure distribution, given the statistical variations expected elsewhere in the injector system.
  • the nominal pressure limit value (that is, power limiting pressure) was set between 20 and 50 psi (typically, at a midpoint of 37.5 psi).
  • An over pressure monitoring circuit was set to trip at a pressure hazard limit or level between 50 and 75 psi (typically, 65.5 psi).
  • the power limiting pressure was chosen to fall in the center of the power or pressure limited operating range.
  • the injector systems of FIGS. 1A through 3C operate over a range of pressures when power limited because of compliance in the system when measuring fluid pressure indirectly. This compliance will be discussed in greater detail below in connection with system specifications and calibration.
  • a minimum pressure of 30 psi at the syringe tip is preferably achieved with an upper pressure limit of 50 psi.
  • the minimum pressure specification is determined by ensuring that the motor (at the power limit) can generate enough force to overcome drive and syringe inefficiencies and losses in addition to 30 psi of fluid pressure.
  • the upper pressure limit specification is met by ensuring that the power delivered to the drive mechanism (for example, motor current) is limited so that the amount of torque generated at the motor output is not large enough to exceed the upper pressure limit of 50 psi at the syringe.
  • the total equivalent pressure variation in system components preferably does not exceed ⁇ 10 psi assuming a nominal maximum pressure (that is, a power limiting pressure) of 40 psi. Since substantial variation in motor and drive efficiency is expected, some form of calibration may be desirable to relate the motor current limit to actual fluid pressure.
  • Syringe friction in this example is constrained by a product specification to be less than or equal to 7.5 psi. Assuming the syringe friction will vary from 2.5 to 7.5 psi, the calibration method used is preferably accurate enough to set the power limiting pressure of the injector to within ⁇ 7.5 psi (10 psi ⁇ (7.5 psi ⁇ 2.5 psi)/2).
  • the current supplied to the motor is limited to meet the 50 psi maximum pressure specification.
  • the limit value preferably accounts for the different components that make up motor current.
  • ⁇ cmd is the commanded acceleration of the motor
  • D is the viscous damping coefficient for velocity dependent torque losses for the system as viewed from the motor shaft (motor viscous damping plus reflected load damping)
  • I A is the motor armature current
  • J is the inertia at the motor shaft (armature inertia plus reflected inertia)
  • K T is the motor torque constant
  • ⁇ p is the portion of motor torque that contributes to pressure in the syringe
  • ⁇ f is the portion of motor torque that is used to overcome motor and system friction losses
  • ⁇ cmd is the commanded velocity of the motor
  • the set motor current limit preferably accounts for the components of the motor current that contribute to motor acceleration, motor velocity, and system frictional losses. These components can be accounted for by using design values, or for more accuracy, by characterizing values for a system using a pressure calibration process.
  • Pressure calibration is particularly desirable in the case of tight pressure specifications. Once again, pressure is limited to the upper pressure limit by limiting the current available to the motor in this example. However, that current goes through several transformations before emerging from the syringe tip as pressure:
  • Torque is magnified through a gear train
  • Torque becomes linear force via a lead or ball screw
  • a carefully executed calibration procedure performed once during manufacture, can substantially reduce or eliminate the contributions of part-to-part variation, and variation over velocity and acceleration. This calibration procedure does not account for contributions of the syringe and variations over position, temperature, and life. On a unit-to-unit basis, calibration can also identify units for rejection which exhibit excessive variation over position. Proper motor selection can keep variation over temperature to a manageable level. If variation over life is large systematically, however, periodic auto-calibration is desirable.
  • the drive member can be used occasionally to advance the plunger with no fluid in the syringe to measure the contribution of syringe friction. Periodic auto-calibration in the case of the use of a force sensor or pressure transducer to measure fluid pressure is discussed below.
  • motor converts current into torque as set forth in equation 2:
  • ⁇ g is the generated torque
  • K t is the motor's torque constant
  • J is the equivalent inertial load at the motor
  • B is the equivalent viscous damping (friction) at the motor
  • is the velocity
  • ⁇ L is the constant opposing torque (friction and losses) at the motor
  • these three components are characterized at least at the pressure minimums and maximums (30 and 50 psi in this example).
  • steady-state moves are preferably performed with a known load at different velocities, while measuring the motor current.
  • it can be determined whether or not the variations of the mechanics over position are acceptable. If so, then the data from the different velocities can be fit to a line (or parabola, if the data warrants), yielding the second and third components of equation 4.
  • current measurements are preferably taken during standard accelerations. Given that the current, the second component of equation 4, and third component of equation 4 are known, the first component of equation 4 can be calculated.
  • these functions can monitor for over-rate, under-rate, over-volume, over-pressure and unintended piston motion conditions (fault conditions).
  • these monitors deactivate a safe relay, which has the function to remove power from the drive mechanism (for example, by cutting off current from a motor) in the case of a safety fault condition.
  • the safe relay can, for example, be a mechanical relay, a solid-state relay, or any other device that can be used to interrupt or remove power from the motors or motivation device.
  • the safe relay device is activated by the system to allow power to the motor and when deactivated, either by command or through a fault condition, is deactivated to interrupt or remove power.
  • An over-pressure circuit can, for example, be a hardware safety circuit or a software component that is designed, for example, to deactivate the safe relay and remove power from the drive to prevent the generation of a hazardous pressure level as described above.
  • the monitor preferably operates by measuring and comparing an average value of the drive power (that is, motor current) and removing power from the drive if it exceeds a maximum threshold level (that is, the motor current corresponding to the pressure hazard limit).
  • An over-rate monitor circuit preferably includes a safety circuit that is designed to deactivate the safe relay to remove power from the drive to prevent the generation of hazardous flow rates.
  • the monitor operates by measuring the piston position with a position sensor and differentiating to obtain an estimate of piston velocity (flow rate).
  • a velocity sensor such as a tachometer could be used to measure flow rate directly.
  • the safe relay is preferably deactivated and power removed from the drive.
  • an under-rate or stall condition can be monitored.
  • the measured flow rate is compared to the programmed flow rate. If the measured flow rate falls below the programmed flow rate by a set amount (set by a threshold level) the safe relay is preferably deactivated and power removed from the drive.
  • a stall condition can be caused, for example, by a blockage in the fluid path, which can be of increased concern when the injector is operating in a power limited state.
  • An over-volume monitor preferably includes a safety circuit that is designed to deactivate the safe relay to remove power from the drive to prevent excess volume from being administered to a patient.
  • the monitor preferably operates by measuring the piston position and comparing it to a target position based on the programmed flow rate/volume. If the measured piston position exceeds the programmed target position (volume) by more than a set amount, the safe relay is preferably deactivated and power is removed from the drive.
  • An unintended motion monitor preferably includes a safety circuit that is designed to deactivate the safe relay to remove power from the drive to prevent unintended movement of the piston, which could cause unintended injection or aspiration, when the injector system is supposed to be in an idle state.
  • the monitor preferably operates by monitoring the forward and reverse piston position motion when the injector system is in an idle state. If the net forward or reverse position exceeds a set travel amount, the safe relay is deactivated and power is removed from the drive.
  • the injector systems of FIGS. 1A through 3C control injection fluid flow until a power limit value is reached.
  • the injector systems maintain the delivered fluid flow rate to an operator-programmed value or setting providing the required pressure as needed based on the restriction of the fluid delivery path.
  • the injector systems deliver whatever flow rate is possible at the power limit until the operator determined fluid volume is delivered, given the pressure generated and disposable set used.
  • the achieved flow rate can be significantly below the programmed value and the injection will be terminated (a stall condition). If for any reason the power limit fails and the pressure exceeds a pressure hazard limit, an over pressure monitor detects the condition and stops fluid delivery.
  • FIGS. 4A through 5C Another embodiment of an injector system of the present invention is illustrated in FIGS. 4A through 5C.
  • pressure measurement is improved by using a more direct measurement thereof than motor current.
  • FIG. 5A for example, one can measure the force (using, for example, a strain gauge) on the mechanical assembly that supports the drive train or syringe and convert or relate the measured force to fluid pressure.
  • a sensor can also be positioned to measure the force on the injector piston as illustrated in FIG. 5A.
  • actual fluid pressure can be measured via, for example, a pressure transducer or sensor in the fluid path as illustrated in FIG. 5A.
  • FIGS. 5B and 5C illustrate one aspect of the present invention in which strain gauges 530 are placed in connection with a mechanical drive rear plate 510 of an injector (such as the Spectris injector available from Medrad, Inc. of Indianola, Pennsylvania, now shown in FIGS. 5B and 5C), which secures ball screw thrust bearings for each of two pistons inside the injector head housing (not shown).
  • the syringe plungers are driven by these pistons as described above.
  • Rear plate 510 is the primary load bearing plate within the injector head and, therefore, provides a strain response that is directly proportional to syringe pressure.
  • the strain on rear plate 510 can be measured by using the voltage output of strain gages 530 bonded directly to the surface of rear plate 510 . This voltage output can be translated to a pressure value.
  • strain gauges 530 are configured as a Wheatstone bridge. There are two full bridges mounted to rear plate 510 with one bridge mounted on the front (syringe) side (FIG. 5B) and one bridge mounted on the rear side (FIG. 5C). Each bridge includes four strain gauges 530 , two mounted on the syringe side of the rear plate and two mounted on the rear side (see FIGS. 5 B and SC). Strain gauges 530 function by measuring changing voltage resistance values within each gauge as the strain on the surface of the plate 510 (to which the gauge has been mounted) changes in magnitude. This strain occurs when the piston is under load (such as during an injection) and thus transfers it's stress back to rear plate 510 .
  • Reading the output voltage from all four strain gauges 530 simultaneously eliminates any apparent fluctuation within the pressure readings caused by an inherent wobble that occurs while the piston is in motion.
  • the full-scale voltage of strain gauges 530 corresponded to a strain of 1000 ⁇ (microstrain) at 300 lbs of piston load.
  • Span resistors 540 can be mounted on the syringe side of rear plate 510 to adjust the bridge output so that one transducer bridge produced a similar output to another bridge mounted onto a different plate 510 .
  • strain gauges 530 and span resistors 540 were bonded to rear plate 510 using an epoxy. Prior to bonding, a surface preparation process as known in the art was performed to provide an adequate bonding surface for the epoxy.
  • the material selected for the rear plate construction was Aluminum 2024-T351.
  • Strain gauges 530 were J 2 A-13-S033P-350 strain gauges available from Measurements Group, Inc of Raleigh, N.C. Strain gauges 530 were attached to rear plate 510 using M-Bond 610 epoxy available from Measurements Group, Inc.
  • strain gauges 530 were bonded to rear plate 510 , they were coated with GageKote# 8 (an acrylic compound that creates a transparent coating between 5-10 mils thick per coat), available from JP Technologies Inc. of San Bernadino, Calif., to anchor the wiring directly to rear plate 510 .
  • GageKote# 8 an acrylic compound that creates a transparent coating between 5-10 mils thick per coat
  • the strain level preferably does not exceed 1000 ⁇ at the area where strain gauges 530 were mounted to rear plate 510 .
  • rear plate 510 was designed such that strain gauges 530 experience 1000 ⁇ at a maximum expected cyclic load condition at 300 lbs of piston load.
  • the maximum expected static load on rear plate 510 was 450 lbs, which translated to 1500 ⁇ at the area where strain gauge 530 was mounted.
  • channels 550 were machined in a pattern around the main bearing areas 560 to produce a symmetrical load condition about the bearing.
  • strain gauges 530 were placed as shown in FIGS. 5B and 5C on both the front and back of rear plate 510 .
  • the symmetrical constraints of the beams allow for piston wobble, which can increase and decrease the load in an equal and opposite manner from one beam to the other, essentially averaging the strains so that there is a stable bridge output.
  • the servo controlling fluid flow rate and volume of fluid delivered can be generally separate in operation from a safety (pressure) monitoring system.
  • the servo controls only the flow rate of the fluid and the volume of the fluid delivered.
  • there is no motor current feedback control loop within the servo control. Fluid flow rate and volume are directly related to the velocity and position of the drive member, respectively, and can be controlled, for example, through feedback of position as illustrated in FIGS. 4A and 4B.
  • a pressure hazard limit is preferably set at a level to prevent, for example, failure (or bursting) of any component of the fluid path or disposable set.
  • an injection procedure is preferably ceased, for example, by preventing current from reaching the motor.
  • a non-mechanical drive inhibitor is provided that inhibits or disables drive circuits that that are in operative connection with power transducers that act as current amplifiers to power the motor.
  • the drive inhibitor generally performs the functions of the mechanical safe relay discussed in connection with FIGS. 1 through 3C in this embodiment.
  • mechanical embodiments of safe relays are expensive and include magnetic components the can malfunction and/or create artifacts in magnetic resonance environments.
  • a pressure that is lower than the pressure hazard limit is preferably chosen/identified at which the injector system becomes power limited.
  • current delivered to the motor can be clamped via a current clamp as described above once the power limit pressure is measured.
  • the power limit can, for example, be activated in real time during an injection procedure by monitoring the force sensor or transducer and setting the power limit (for example, by setting maximum motor current) when the measured force reaches a value corresponding to the power limiting pressure.
  • FIG. 4B illustrates another embodiment of an injector system of the present invention in which a servo controller controls only fluid flow rate and volume via position feedback as described above.
  • the servo controller sends a signal to a commutator that, in turn, transmits timed signals to a current amplifier including a plurality of level shifters (L/S) or power transducer.
  • the commutator energizes the level shifters in sequence, each for a specific amount of time. The amount of time each level shifter is energized controls the motor power.
  • a safety (pressure) monitoring system monitors the fluid pressure via a force sensor as described above.
  • the safety monitoring system detects that the power limiting pressure has been reached, a signal is sent to the commutator that sets a power clamp as described above by limiting the amount of time the level shifters are energized. If the safety monitoring system detects that the hazard pressure limit has been reached, a signal is sent to the current amplifier that disables the level shifters, thereby stopping the injection procedure.
  • the servo controller and the safety monitoring system act independently.
  • the safety monitoring system can be viewed as a safety or pressure override system in that the settings programmed into the servo controller by the system operator can be overridden by the safety monitoring system upon the measurement of the power limiting pressure or the pressure hazard limit.
  • Periodic pressure measurement recalibration can, for example, be performed by measuring force when the system is in a known state (for example, it is known that a syringe is not attached). The system can determine the difference between the measured force and the force that is reasonably expected to be measured when the system is in the known state, and can recalibrate the force sensing system accordingly.
  • the injector Because the system is effectively recalibrated during every power-limited injection, the injector also has the capability to “learn” from past trends. For example, software algorithms, as known in the computer arts, can use information recorded in memory to learn the behavior of the system and adjust for expected performance changes based on those trends. Calibration changes can, for example, be predicted.
  • the pressure monitoring system determines if the power limiting pressure has been reached and the current/power is clamped at that point.
  • the improved pressure measurement in the embodiment of FIGS. 4A and 4B as compared to deriving fluid pressure from motor current results in a narrowed power limited operating range.
  • the more direct measurement of pressure greatly reduces or eliminates the uncertainty resulting from tolerances of the injector system.
  • a gap between the upper limit of the power limited range and the pressure hazard limit assists in preventing such nuisance shutdowns.
  • the greater tolerances involved in using motor current to measure pressure render it difficult to achieve the proper balance without setting the pressure hazard limit level to an undesirably high level.
  • the disposable components of a disposable set can, for example, include a syringe and the fluid path (for example, connecting tubing etc.) between the syringe and the patient as described above.
  • the pressure monitoring systems of FIGS. 4A through 5B also facilitate adjustment of the pressure hazard limit and/or the power limiting pressure by the operator of the injector system.
  • the pressure hazard limit and the power limiting pressure are related (for example, mathematically coupled in software) such that a sufficient gap is maintained between the pressure hazard limit and the power limiting pressure to substantially reduce the likelihood of nuisance shutdowns of the injector system.
  • the injector systems of FIGS. 4A through 5C control fluid flow until a power limit pressure is measured.
  • the injector systems maintain the delivered fluid flow rate to an operator-programmed value, providing the required pressure as needed based, for example, on the disposable set in place.
  • the system clamps the power delivered to the motor at that point and delivers whatever flow rate is possible at that power limit. If the flow rate achieved is significantly below the programmed value (for example, less than or equal to 10% of the programmed flow rate as averaged over 3 minutes in the ml/min range or as averaged over 3 seconds in the ml/s range), the injection is preferably terminated and the injector disarmed (a stall condition). If for some reason the power limit fails and the measured pressure exceeds a pressure hazard limit (for example, for a defined period of time), fluid delivery is preferably stopped and the injector disarmed.
  • a pressure hazard limit for example, for a defined period of time
  • the injector systems deliver the volume of fluid programmed by the operator.
  • the flow rate programmed by the operator is achieved, as long as the measured fluid pressure developed within the injector system is less than the power limiting pressure.
  • the injection is ceased when the programmed volume of fluid has been delivered. If, for any reason, the programmed flow rate is not achieved, the time of the injection is extended to deliver the programmed volume.
  • the power generated by the injector is reduced by the system to keep the operation safe at an internal pressure lower than the pressure hazard limit. The effect of such power limiting is to limit the flow rate that can be achieved with a given disposable set and injection fluid.
  • current injectors include a housing that encompasses the control and drive mechanisms for the injector.
  • the housing typically also includes a syringe interface to which a syringe can be connected.
  • Such injector housings are often connected to a mobile stand to facilitated positioning of the injector housing.
  • Many such injector housings are also made to be rotatable about an axis to, for example, further facilitate positioning.
  • rotation of the injector housing also enables a syringe connected thereto to be directed upwards to expel air from the syringe (by advancing the syringe plunger in a forward direction).
  • rotating the syringe downward during an injection procedure minimizes the risk of injecting air.
  • At least one syringe interface module is made to be separately movable from the remainder of the injector system.
  • the syringe interface module includes one or more syringe interfaces on a housing thereof for connecting one or more syringes thereto.
  • the syringe interface module also includes at least one drive member (for example, piston) housed therein that is adapted to pressurize fluid within the syringe.
  • the syringe interface module can also include a drive mechanism such as a motor to supply power to the drive member.
  • the drive mechanism can also be remote from the syringe interface module, but in operative connection with the drive member.
  • an electric motor can be connected to the drive member remotely via a flexible shaft.
  • Suitable flexible shafts are disclosed, for example, in U.S. Pat. No. 5,494,036, the disclosure of which is incorporated herein by reference.
  • the separately movable syringe module of the present invention greatly improves the ease of use of the injector systems of the present invention by, for example, expanding the locations/positions in which the injector system can be used.
  • an injector system 200 includes an injector having a control unit 210 , a syringe interface module 220 and a syringe 300 .
  • Syringe interface module 220 includes an interface 222 for connecting syringe 300 thereto.
  • Syringe interface module 220 also houses a powered drive member or piston that controls movement of a syringe plunger 310 (see FIG. 5A).
  • Syringe interface module 220 also houses a motor (see FIGS. 5A) in operative connection with the piston. The motor is in communicative connection with control circuitry housed in control unit 210 to supply the motor with control signals as known in the art.
  • syringe injection module 220 can also include an independent power source such as a battery (not shown).
  • a portable injector stand 400 supports control unit 210 of injector system 200 .
  • Injector system 200 can also include a remote control panel 240 that is in communication with control unit 210 .
  • Control switches 212 are preferably used to program control parameters for an injection procedure. Some or all of control switches 212 can be duplicated on remote control panel 240 .
  • a number of switches 224 can also be provided on syringe interface module 220 to manually control motion of the drive member (for example, forward, reverse, stop etc.).
  • FIG. 6D illustrates an embodiment of a system for carrying out a medical imaging procedure including an imaging apparatus 260 having an input device 262 (for example, a keyboard).
  • the system preferably further includes one or more attachment members 270 for attaching and/or holding remote control panel 240 in the vicinity the imaging apparatus so that an operator can more readily operate both the imaging apparatus and the injector generally simultaneously.
  • Syringe interface module 220 is rotatable relative to control unit 210 about an axis A. Because syringe interface module 220 is rotatable relative to control unit 210 , syringe loading and multiple injection positions are facilitated while providing the operator with easy and consistent access to control switches 212 of control unit 210 . The use of injector system 200 in different positions/locations is also facilitated.
  • FIG. 6B illustrates syringe interface module 220 in an upright position in both a front view and a side view.
  • injection fluid is aspirated into syringe 300 by retracting plunger 310 .
  • air is preferably expelled while syringe interface module 220 is in an upright position.
  • syringe interface module 220 is rotated downward as illustrated in FIG. 6A (front view) and 6 C (side view) for injection.
  • FIG. 6C illustrates an example of a range of injection positions for syringe interface module 220 .
  • FIG. 7 illustrates an embodiment of the present invention in which an injector system 200 a includes two syringe interface modules 220 a and 220 a ′ to which syringes 300 a and 300 a ′, respectively, are attached.
  • Each of syringe interface modules 220 a and 220 a ′ are rotatably attached to control unit 210 a about an axis A.
  • syringe interface module 220 a is rotated downward, while syringe interface module 220 a ′ is rotate upward.
  • an injector system 200 b includes a syringe interface module 220 b that includes two syringe interfaces 222 b and 222 b ′ to which syringes 300 b and 300 b ′, respectively, are connected.
  • Syringe interface module 220 b is rotatably connected to control unit 210 b .
  • Syringe interface module 220 b preferably includes two drive members (not shown) housed therein for independent control of fluid injection from each of syringes 300 b and 300 b′.
  • FIG. 9 illustrates an embodiment of an injector system 200 c including a syringe interface module 220 c (with attached syringe 300 c ) that is physically disconnected from control unit 210 c , but is in communicative connection with control unit 210 c .
  • syringe interface module 220 c is in communicative connection with control unit 210 c via communication line 350 c , but the communication between control unit 210 c and syringe interface module 220 c can be wireless using wireless communication protocols as well known in the arts.
  • FIG. 9 illustrates an injector system 200 c including a syringe interface module 220 c (with attached syringe 300 c ) that is physically disconnected from control unit 210 c , but is in communicative connection with control unit 210 c .
  • syringe interface module 220 c is in communicative connection with control unit 210 c via communication line 350 c , but the communication between control unit 210
  • syringe interface module 220 c can be placed in virtually any position and/or orientation regardless of the position and/or orientation of control unit 210 c .
  • the relatively small size and increased mobility (as compared to current injectors) of syringe interface module 220 c enable syringe interface module 220 c to be lain next to a patient.

Abstract

A fluid delivery system includes a control unit having one or more devices for controlling a fluid injection, a syringe having a body and a plunger movably disposed within the body, and a syringe interface module separate from but in communication with the control unit. The syringe interface module includes a module housing, a syringe interface on the module housing that is adapted to connect the syringe to the module housing, and a drive member operable to advance the plunger of the syringe.

Description

    CROSS -REFERENCE TO RELATED APPLICATIONS
  • This application is a division of application Ser. No. 09/721,427, filed on Nov. 22, 2000, which claims priority to U.S. Provisional Patent Application Serial No. 60/167,309, filed on Nov. 24, 1999, the disclosures of which are incorporated herein by reference.[0001]
  • BACKGROUND OF THE INVENTION
  • The present invention relates generally to injectors, injector systems and control of injectors and injector systems, and, especially, to injectors, injector systems and injector control for use in medical procedures in which a fluid is injected into a patient. [0002]
  • In many medical diagnostic and therapeutic procedures, a physician or other person injects a patient with a fluid. In recent years, a number of injector-actuated syringes and powered injectors for pressurized injection of fluids such as contrast media have been developed for use in procedures such as angiography, computed tomography, ultrasound and NMR/MRI. In general, these powered injectors are designed to deliver a preset amount of contrast media at a preset flow rate. [0003]
  • To ensure the safety of the patient, the operation of a powered injector should be carefully controlled. For example, it is desirable not to exceed a certain fluid pressure during an injection procedure. In addition to potential hazards to the patient (for example, vessel damage) and potential degradation of the diagnostic and/or therapeutic utility of the injection fluid, excessive pressure can lead to equipment failure. For example, because of the potential of cross-contamination between patients, the syringe and tubing used to carry fluid to a patient are typically changed on a per-patient basis. Such disposable syringes and other fluid path components (sometimes referred to collectively as a “disposable set”) are typically fabricated from plastics of various burst strengths. If the injector causes pressure in the fluid path to rise above the burst strength of a disposable fluid path element, the fluid path element will fail. [0004]
  • In controlling system or injection pressure, current injectors use motor current as an indication of system pressure. This technique has inherent accuracy problems, as there are many variables between the parameter being measured (motor current) and the parameter of interest (fluid pressure). These include, for example, measurement inaccuracies, motor torque constant variation, motor variation with temperature, frictional effects in the drive train, and frictional effects in the syringe. In general, any control algorithm must allow for such errors and must make a conservative estimate of fluid pressure to prevent actual fluid pressure from reaching a hazardous value. [0005]
  • Current systems typically predefine a conservative pressure (that is, motor current) control value. As the preset pressure control level is reached, such injectors begin to slow down the flow rate of injection in an effort to stop the build up pressure. At that point, an injector system that was originally intended to servo control the volume and flow rate of the injection fluid begins to servo control pressure. The inaccuracies inherent in using motor current to derive pressure result in a compliant system, and the operation of the servo in that state is oscillatory. Pressures in excess of desirable limits can occur, resulting in potentially hazardous operation of the injector. [0006]
  • In addition to problems of control with current injector systems, many such systems lack convenience and flexibility in the manner in which the injector systems must be operated. In that regard, the complexity of medical injection procedures and the hectic pace in all facets of the health care industry place a premium on the time and skills of an operator. [0007]
  • It is thus very desirable to develop injectors exhibiting improved operative control as well as injectors exhibiting improved ease of use. [0008]
  • SUMMARY OF THE INVENTION
  • In one aspect, the present invention provides an injector for use in injecting a fluid in a medical injection procedure. The injector includes a drive mechanism to pressurize the fluid; a sensor to measure a variable that is proportional to fluid pressure (that is, a direct or indirect measurement of fluid pressure); and a pressure monitor (for example, including hardwired circuitry and/or software) in communication with the sensor and the drive mechanism to stop the injection procedure when the sensor measures a value of the variable that corresponds to a pressure hazard limit. [0009]
  • Preferably, the pressure monitor further limits power input to the drive mechanism to a power limit once the variable reaches a value that corresponds to a power limiting pressure that is below the pressure hazard limit. In this manner, the pressure hazard limit should never be reached. If, however, the power limiting feature fails, the injector terminates the injection procedure once the pressure hazard limit is reached. [0010]
  • The drive mechanism may, for example, receive power from a motor. In this embodiment, the sensor can, for example, measure motor current. The pressure monitor can limit the motor current to a value corresponding to the power limiting pressure. The power limit is typically predetermined or preset for the injector in this embodiment. [0011]
  • In another embodiment, a more direct and accurate manner of measuring fluid pressure than measuring motor current is used. In one embodiment, for example, the sensor measures force exerted upon a component of the drive mechanism or an injector component in connection with the drive mechanism. In general, the sensor can measure force upon any component of the injector that bears a load proportional to the fluid pressure. Particularly in the case that a force sensor (for example, a strain gauge) or pressure transducer is used to measure fluid pressure, setting of the power limit during injector use and periodic auto-recalibration are facilitated. [0012]
  • In another aspect, the present invention provides an injector for use in injecting a fluid in a medical injection procedure including: a drive mechanism to pressurize the fluid; a sensor to measure a variable that is proportional to fluid pressure; [0013]
  • and a pressure monitor in communication with the sensor and the drive mechanism to limit power input to the drive mechanism to a power limit once the variable reaches a value that corresponds to a power limiting pressure. [0014]
  • In a further aspect, the present invention provides an injector system for use in injecting a fluid in a medical injection procedure including a drive mechanism to pressurize the fluid and a control mechanism to control flow rate of the fluid and volume of the fluid injected. The injector further includes a sensor including a force transducer providing a measure of fluid pressure and a pressure monitor in communication with the sensor and the drive mechanism to stop the injection procedure when the sensor measures a pressure corresponding to a pressure hazard limit. The pressure monitor also preferably limits power input to the drive mechanism to a power limit when the sensor measures a pressure corresponding to a power limiting pressure. As discussed above, the power limiting pressure is less that the pressure hazard limit. [0015]
  • In another aspect, the present invention provides an injector system for use in injecting a fluid in a medical injection procedure including a drive mechanism to pressurize the fluid and a control mechanism to control flow rate of the fluid and volume of the fluid injected (typically on the basis of flow rate and volume setting input by the user of the injector using a data entry mechanism as known in the art). The injector also includes a safety system including a sensor (for example, a force transducer) to provide a measure of fluid pressure. The safety system also includes a pressure monitor in communication with the sensor and the drive mechanism. The pressure monitor is adapted to override settings of the control mechanism and stop the injection procedure when the sensor measures a pressure corresponding to a pressure hazard limit. Moreover, the pressure monitor is adapted to override settings of the control mechanism to limit power input to the drive mechanism to a power limit when the sensor measures a pressure corresponding to a power limiting pressure, the power limiting pressure being below the pressure hazard limit. In general, the power limit is preferably the power being supplied to the drive mechanism when the power limiting pressure is measures. [0016]
  • In a further aspect, the present invention provides a method of controlling an injector used in a medical injection procedure. The method includes measuring a variable that is proportional to fluid pressure, and limiting power input to a drive mechanism of the injector to a power limit once the variable reaches a value that corresponds to a power limiting pressure. [0017]
  • The method may also include terminating the injection procedure if the value of the variable corresponds to a pressure hazard limit, the pressure hazard limit being greater than the power limiting pressure. [0018]
  • In another aspect, the present invention provides an injector for use with a syringe having a plunger disposed therein to inject a fluid in a medical procedure. The injector includes a control unit including a control unit housing and control circuitry disposed within the control unit housing, and at least one syringe interface module including a module housing, at least one syringe interface on the module housing that is adapted to connect the syringe to the module housing and at least one drive member within the module housing to control motion of the plunger, the module housing being moveable relative to the control unit housing. [0019]
  • In one embodiment the module housing is rotatable relative to the control unit housing. In another embodiment the module housing is physically detached from the control unit housing. [0020]
  • In still a further aspect, the present invention provides a system for performing a medical imaging procedure including an injector, the injector including a portable remote control panel, an imaging apparatus, and an attachment member in the vicinity of (or attached to) the imaging apparatus. The attachment member is adapted to attach or support the remote control panel in the vicinity of the imaging apparatus to facilitate generally simultaneous access by the operator to both the remote control panel and the imaging apparatus while performing the medical imaging procedure.[0021]
  • Numerous other objects and advantages of the present invention will be apparent from the following drawings and detailed description of the invention and its preferred embodiments. [0022]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1A illustrates a schematic representation of one embodiment of a fluid delivery system for use in the present invention. [0023]
  • FIG. 1B illustrates an embodiment of pressure limiting through limiting motor current. [0024]
  • FIG. 2 illustrates the relationship between motor current and system pressure for an injector. [0025]
  • FIG. 3A illustrates a predicted maximum pressure distribution. [0026]
  • FIG. 3B illustrates an operating range over which certain injectors having a set power limit may operate. [0027]
  • FIG. 3C illustrates a schematic representation of the embodiment of FIG. 1A including a monitoring system for various conditions. [0028]
  • FIG. 4A illustrates a schematic representation of an embodiment of an injector system of the present invention in which a force sensor or transducer is used to measure pressure. [0029]
  • FIG. 4B illustrates a schematic representation of an embodiment of the injector system of FIG. 4A. [0030]
  • FIG. 4C illustrates a power limited operating range of the injector systems of FIGS. 4A and 4B. [0031]
  • FIG. 5A illustrates a cross-sectional view of an embodiment of a syringe interface module in which fluid pressure is measured via a transducer/sensor. [0032]
  • FIG. 5B illustrates a front plan view of a rear plate including strain gauges. [0033]
  • FIG. 5C illustrates a rear plan view of the rear plate of FIGS. 5B including strain gauges. [0034]
  • FIGS. 6A through 6C illustrate another embodiment of an injector of the present invention in which an syringe interface module is movable/rotatable relative to a control unit of the injector. [0035]
  • FIG. 6D illustrates an embodiment of a system of the present invention in which an imaging unit is provided with a connector for attaching an injector remote control panel to the imaging unit. [0036]
  • FIG. 7 illustrates an embodiment of an injector comprising two syringe interface modules rotatably connected to a control unit housing. [0037]
  • FIG. 8 illustrates an embodiment of an injector comprising a syringe interface module rotatably connected to a control unit housing and having two syringe interfaces. [0038]
  • FIG. 9 illustrates an embodiment of an injector comprising a syringe interface module physically disconnected from a control unit housing.[0039]
  • DETAILED DESCRIPTION OF THE INVENTION
  • FIG. 1A illustrates several components of a fluid delivery system for use in the present invention. The fluid delivery system includes an operator interface connected to a controller, which may include a computer (including, for example, a [0040] processing unit 10 and a memory 20), that is supplied by a power source. The power source may, for example, include a battery or other electrical power supply. In operation, the controller sends activation energy to the actuator, which powers a drive mechanism. The drive mechanism is connected to a fluid chamber such as a syringe (see, for example, FIG. 5A) that contains a volume of injection fluid to be pressurized. The fluid chamber connects to the patient through a fluid path. The fluid path may, for example, include sterile tubing that connects to the patient.
  • Unlike prior injectors, the control systems of the injectors of the present invention preferably treat pressure as a hazard, rather than as a variable to be controlled. For example, a pressure hazard limit can be set as a trip point in the present invention. When pressure in the system (as measured directly or indirectly) reaches the pressure hazard level, the injection may be terminated. Preferably, the performance of the injector is further limited in a manner to ensure that the user is not inconvenienced by continual shutdowns during normal operations. In one embodiment, the power delivered to the drive mechanism is limited in a manner so that the pressure hazard limit or upper hazard level is not reached. [0041]
  • In the embodiment of FIG. 1B, for example, the actuator includes a DC brush type motor. The power delivered to the drive mechanism can be limited by presetting a clamp on the maximum current that can be delivered to the motor. The maximum current corresponds to a fluid pressure (the “power limiting pressure”) that is below the pressure hazard limit. With the drive power limited to the set value (that is, the power limit), the injector will not be able to generate enough pressure to cause a hazard (that is, to reach the pressure hazard limit). If pressure in the system rises to the point where the injector enters a state of power limited operation (that is, the current has reached the set maximum current), operation of the injector will be smooth rather than oscillatory (as experienced with currently available injectors). Currently available injectors adjust the motor current based on both a sampled current and an actual, estimated or programmed flow rate of the delivery system. Unlike currently available injectors, the injector of the present invention is not tracking the operation of a compliant system, but is simply limiting current delivered to the motor to the maximum current. The injector control of the present invention thus results in improved smoothness of flow rate when the injector is in a limiting state of operation. [0042]
  • Motor current can be limited through electronic circuitry (as known in the art) that samples the motor current, compares the magnitude to the threshold set level and limits the applied current to the device. Motor current can, for example, be controlled by a pulse width modulation (PWM) type drive with a current limit comparator. As known in the art and used herein, the terms “pulse width modulation” or “PWM” refer to an encoding scheme in which a quantity is encoded by the proportion of a fixed time period in which a signal is held active. The proportion is referred to as the “duty cycle,” and is often referred to in percent. In this embodiment, when motor current exceeds the set threshold power limit level, the PWM cycle in progress is preferably prematurely terminated and held off for a fixed time period, reducing current to the motor until the next cycle. [0043]
  • In effect, the control process of the present invention as described above limits output fluid power (flow rate×pressure) by limiting electrical input power (current×voltage) to the motor by limiting the maximum value of motor current. The relationship between motor current and pressure is illustrated in FIG. 2. [0044]
  • In one embodiment, the limit threshold for motor current was fixed at a single value for the injector and was not flow rate dependent. The variation in the predicted pressure was found to be small enough to allow all injector systems of a particular type to be constructed with such a fixed limit, thereby avoiding the need for pressure calibration. FIG. 3A illustrates a predicted maximum pressure distribution, given the statistical variations expected elsewhere in the injector system. [0045]
  • In one set of exemplary studies, the nominal pressure limit value (that is, power limiting pressure) was set between 20 and 50 psi (typically, at a midpoint of 37.5 psi). An over pressure monitoring circuit was set to trip at a pressure hazard limit or level between 50 and 75 psi (typically, 65.5 psi). In general, the power limiting pressure was chosen to fall in the center of the power or pressure limited operating range. The injector systems of FIGS. 1A through 3C operate over a range of pressures when power limited because of compliance in the system when measuring fluid pressure indirectly. This compliance will be discussed in greater detail below in connection with system specifications and calibration. [0046]
  • In the power limited operating range of another example of the present invention illustrated in FIG. 3B, a minimum pressure of 30 psi at the syringe tip is preferably achieved with an upper pressure limit of 50 psi. The minimum pressure specification is determined by ensuring that the motor (at the power limit) can generate enough force to overcome drive and syringe inefficiencies and losses in addition to 30 psi of fluid pressure. The upper pressure limit specification is met by ensuring that the power delivered to the drive mechanism (for example, motor current) is limited so that the amount of torque generated at the motor output is not large enough to exceed the upper pressure limit of 50 psi at the syringe. [0047]
  • To meet pressure specification, the total equivalent pressure variation in system components, including the syringe, preferably does not exceed±10 psi assuming a nominal maximum pressure (that is, a power limiting pressure) of 40 psi. Since substantial variation in motor and drive efficiency is expected, some form of calibration may be desirable to relate the motor current limit to actual fluid pressure. Syringe friction in this example is constrained by a product specification to be less than or equal to 7.5 psi. Assuming the syringe friction will vary from 2.5 to 7.5 psi, the calibration method used is preferably accurate enough to set the power limiting pressure of the injector to within±7.5 psi (10 psi−(7.5 psi−2.5 psi)/2). [0048]
  • The current supplied to the motor is limited to meet the 50 psi maximum pressure specification. The limit value preferably accounts for the different components that make up motor current. At the motor, the motor current can be expressed in [0049] equation 1 as follows (as viewed from the motor output shaft): I A = 1 K T · ( J · α cmd + D · ω cmd + τ p + τ f ) Equation 1
    Figure US20040015124A1-20040122-M00001
  • where [0050]
  • α[0051] cmd is the commanded acceleration of the motor
  • D is the viscous damping coefficient for velocity dependent torque losses for the system as viewed from the motor shaft (motor viscous damping plus reflected load damping) [0052]
  • I[0053] A is the motor armature current
  • J is the inertia at the motor shaft (armature inertia plus reflected inertia) [0054]
  • K[0055] T is the motor torque constant
  • τ[0056] p is the portion of motor torque that contributes to pressure in the syringe
  • τ[0057] f is the portion of motor torque that is used to overcome motor and system friction losses
  • ω[0058] cmd is the commanded velocity of the motor
  • The set motor current limit preferably accounts for the components of the motor current that contribute to motor acceleration, motor velocity, and system frictional losses. These components can be accounted for by using design values, or for more accuracy, by characterizing values for a system using a pressure calibration process. [0059]
  • Pressure calibration is particularly desirable in the case of tight pressure specifications. Once again, pressure is limited to the upper pressure limit by limiting the current available to the motor in this example. However, that current goes through several transformations before emerging from the syringe tip as pressure: [0060]
  • Current becomes torque via the motor's torque constant [0061]
  • Torque is magnified through a gear train [0062]
  • Torque becomes linear force via a lead or ball screw [0063]
  • Linear force on the plunger becomes pressure in the syringe [0064]
  • Each of these transformations can contain substantial amounts of variation, for example: [0065]
  • from part to part and/or lot to lot in manufacturing [0066]
  • as a function of injector position (or angle) [0067]
  • as a function of syringe velocity [0068]
  • as a function of plunger acceleration [0069]
  • as a function of temperature [0070]
  • as a function of injector use and/or wear (sometimes referred to as “run-in”) [0071]
  • A carefully executed calibration procedure, performed once during manufacture, can substantially reduce or eliminate the contributions of part-to-part variation, and variation over velocity and acceleration. This calibration procedure does not account for contributions of the syringe and variations over position, temperature, and life. On a unit-to-unit basis, calibration can also identify units for rejection which exhibit excessive variation over position. Proper motor selection can keep variation over temperature to a manageable level. If variation over life is large systematically, however, periodic auto-calibration is desirable. [0072]
  • In the case that motor current is used to indirectly measure fluid pressure, for example, the drive member can be used occasionally to advance the plunger with no fluid in the syringe to measure the contribution of syringe friction. Periodic auto-calibration in the case of the use of a force sensor or pressure transducer to measure fluid pressure is discussed below. [0073]
  • In general, motor converts current into torque as set forth in equation 2:[0074]
  • τg =K t ·I  Equation 2
  • where [0075]
  • τ[0076] g is the generated torque
  • K[0077] t is the motor's torque constant
  • I is the current drawn by the motor [0078]
  • The generated torque is divided as follows in equation 3:[0079]
  • τg =J·α+B·ω+τL  Equation 3
  • where [0080]
  • J is the equivalent inertial load at the motor [0081]
  • α is the acceleration [0082]
  • B is the equivalent viscous damping (friction) at the motor [0083]
  • ω is the velocity [0084]
  • τ[0085] L is the constant opposing torque (friction and losses) at the motor
  • Thus, the motor current goes to three components:[0086]
  • I=(J/K t)·α+(B/K t)·ω+(τL /K t)  Equation 4
  • Preferably, these three components are characterized at least at the pressure minimums and maximums (30 and 50 psi in this example). To accomplish this characterization, steady-state moves are preferably performed with a known load at different velocities, while measuring the motor current. During these steady-state moves, it can be determined whether or not the variations of the mechanics over position are acceptable. If so, then the data from the different velocities can be fit to a line (or parabola, if the data warrants), yielding the second and third components of equation 4. Subsequently, current measurements are preferably taken during standard accelerations. Given that the current, the second component of equation 4, and third component of equation 4 are known, the first component of equation 4 can be calculated. [0087]
  • Once the above procedure has been performed for both 30 and 50 psi, one can determine current limits for all velocities, and an offset to these limits during accelerations. This determination is preferably made by taking the current limit to be midway between the 30 psi and 50 psi values (adjusting for the syringe variations). Should the 30 and 50 psi current values be too close together, this method will not work properly and the unit should be rejected. The calculated current limits are preferably then stored in memory (for example, non-volatile memory or NVRAM ) and used by the injector software during normal operations. [0088]
  • In addition to monitoring for an upper pressure limit as described above, there are several other safety monitor functions that are preferably active during operation of the injector system in the embodiment of FIG. 3C. For example, these functions can monitor for over-rate, under-rate, over-volume, over-pressure and unintended piston motion conditions (fault conditions). In the embodiment of FIG. 3C, these monitors deactivate a safe relay, which has the function to remove power from the drive mechanism (for example, by cutting off current from a motor) in the case of a safety fault condition. The safe relay can, for example, be a mechanical relay, a solid-state relay, or any other device that can be used to interrupt or remove power from the motors or motivation device. in a typical embodiment, the safe relay device is activated by the system to allow power to the motor and when deactivated, either by command or through a fault condition, is deactivated to interrupt or remove power. [0089]
  • An over-pressure circuit can, for example, be a hardware safety circuit or a software component that is designed, for example, to deactivate the safe relay and remove power from the drive to prevent the generation of a hazardous pressure level as described above. The monitor preferably operates by measuring and comparing an average value of the drive power (that is, motor current) and removing power from the drive if it exceeds a maximum threshold level (that is, the motor current corresponding to the pressure hazard limit). [0090]
  • An over-rate monitor circuit preferably includes a safety circuit that is designed to deactivate the safe relay to remove power from the drive to prevent the generation of hazardous flow rates. The monitor operates by measuring the piston position with a position sensor and differentiating to obtain an estimate of piston velocity (flow rate). Alternatively, a velocity sensor such as a tachometer could be used to measure flow rate directly. When compared, if the measured flow rate exceeds a programmed flow rate by a set amount (set by a threshold level) the safe relay is preferably deactivated and power removed from the drive. [0091]
  • In generally the same manner an under-rate or stall condition can be monitored. In the case of under-rate monitoring, the measured flow rate is compared to the programmed flow rate. If the measured flow rate falls below the programmed flow rate by a set amount (set by a threshold level) the safe relay is preferably deactivated and power removed from the drive. A stall condition can be caused, for example, by a blockage in the fluid path, which can be of increased concern when the injector is operating in a power limited state. [0092]
  • An over-volume monitor preferably includes a safety circuit that is designed to deactivate the safe relay to remove power from the drive to prevent excess volume from being administered to a patient. The monitor preferably operates by measuring the piston position and comparing it to a target position based on the programmed flow rate/volume. If the measured piston position exceeds the programmed target position (volume) by more than a set amount, the safe relay is preferably deactivated and power is removed from the drive. [0093]
  • An unintended motion monitor preferably includes a safety circuit that is designed to deactivate the safe relay to remove power from the drive to prevent unintended movement of the piston, which could cause unintended injection or aspiration, when the injector system is supposed to be in an idle state. The monitor preferably operates by monitoring the forward and reverse piston position motion when the injector system is in an idle state. If the net forward or reverse position exceeds a set travel amount, the safe relay is deactivated and power is removed from the drive. [0094]
  • The injector systems of FIGS. 1A through 3C control injection fluid flow until a power limit value is reached. In other words, the injector systems maintain the delivered fluid flow rate to an operator-programmed value or setting providing the required pressure as needed based on the restriction of the fluid delivery path. Once a power limit value is reached, the injector systems deliver whatever flow rate is possible at the power limit until the operator determined fluid volume is delivered, given the pressure generated and disposable set used. In the case of a severe restriction of the fluid path, for example, the achieved flow rate can be significantly below the programmed value and the injection will be terminated (a stall condition). If for any reason the power limit fails and the pressure exceeds a pressure hazard limit, an over pressure monitor detects the condition and stops fluid delivery. [0095]
  • Another embodiment of an injector system of the present invention is illustrated in FIGS. 4A through 5C. In this embodiment of the present invention, pressure measurement is improved by using a more direct measurement thereof than motor current. As illustrated in FIG. 5A, for example, one can measure the force (using, for example, a strain gauge) on the mechanical assembly that supports the drive train or syringe and convert or relate the measured force to fluid pressure. In general, one can measure the force exerted on any injector component that bears a force proportional to the fluid pressure. A sensor can also be positioned to measure the force on the injector piston as illustrated in FIG. 5A. Likewise, actual fluid pressure can be measured via, for example, a pressure transducer or sensor in the fluid path as illustrated in FIG. 5A. Use of a force sensor in connection with the drive train eliminates most tolerances in the interpretation of pressure measurements other than, for example, those caused by the friction of the plunger moving in the syringe. Use of a fluid pressure sensor in the fluid path generally eliminates all tolerances in interpretation. Other methods of measuring fluid pressure suitable for use in the present invention are disclosed, for example, in U.S. Pat. No. 5,808,203, the disclosure of which is incorporated herein by reference. [0096]
  • FIGS. 5B and 5C illustrate one aspect of the present invention in which strain gauges [0097] 530 are placed in connection with a mechanical drive rear plate 510 of an injector (such as the Spectris injector available from Medrad, Inc. of Indianola, Pennsylvania, now shown in FIGS. 5B and 5C), which secures ball screw thrust bearings for each of two pistons inside the injector head housing (not shown). The syringe plungers are driven by these pistons as described above. Rear plate 510 is the primary load bearing plate within the injector head and, therefore, provides a strain response that is directly proportional to syringe pressure. The strain on rear plate 510 can be measured by using the voltage output of strain gages 530 bonded directly to the surface of rear plate 510. This voltage output can be translated to a pressure value.
  • In the embodiment of FIGS. 5B and 5C, [0098] strain gauges 530 are configured as a Wheatstone bridge. There are two full bridges mounted to rear plate 510 with one bridge mounted on the front (syringe) side (FIG. 5B) and one bridge mounted on the rear side (FIG. 5C). Each bridge includes four strain gauges 530, two mounted on the syringe side of the rear plate and two mounted on the rear side (see FIGS. 5B and SC). Strain gauges 530 function by measuring changing voltage resistance values within each gauge as the strain on the surface of the plate 510 (to which the gauge has been mounted) changes in magnitude. This strain occurs when the piston is under load (such as during an injection) and thus transfers it's stress back to rear plate 510. Reading the output voltage from all four strain gauges 530 simultaneously eliminates any apparent fluctuation within the pressure readings caused by an inherent wobble that occurs while the piston is in motion. In one embodiment, the full-scale voltage of strain gauges 530 corresponded to a strain of 1000 με (microstrain) at 300 lbs of piston load. Span resistors 540 can be mounted on the syringe side of rear plate 510 to adjust the bridge output so that one transducer bridge produced a similar output to another bridge mounted onto a different plate 510.
  • In the embodiment of FIGS. 5B and 5C, [0099] strain gauges 530 and span resistors 540 were bonded to rear plate 510 using an epoxy. Prior to bonding, a surface preparation process as known in the art was performed to provide an adequate bonding surface for the epoxy. The material selected for the rear plate construction was Aluminum 2024-T351. Strain gauges 530 were J2A-13-S033P-350 strain gauges available from Measurements Group, Inc of Raleigh, N.C. Strain gauges 530 were attached to rear plate 510 using M-Bond 610 epoxy available from Measurements Group, Inc. Once strain gauges 530 were bonded to rear plate 510, they were coated with GageKote#8 (an acrylic compound that creates a transparent coating between 5-10 mils thick per coat), available from JP Technologies Inc. of San Bernadino, Calif., to anchor the wiring directly to rear plate 510.
  • For [0100] strain gauges 530 of the above embodiment, the strain level preferably does not exceed 1000 με at the area where strain gauges 530 were mounted to rear plate 510. To achieve an output from strain gauges 530 that produced a maximum output and resolution, rear plate 510 was designed such that strain gauges 530 experience 1000 με at a maximum expected cyclic load condition at 300 lbs of piston load. The maximum expected static load on rear plate 510 was 450 lbs, which translated to 1500 με at the area where strain gauge 530 was mounted. To achieve the above-mentioned levels of strain, channels 550 were machined in a pattern around the main bearing areas 560 to produce a symmetrical load condition about the bearing. Creation of a strain area allowed ready adjustment (using, for example, finite element analysis) of the geometry until the optimal strain levels were achieved. In this embodiment, strain gauges 530 were placed as shown in FIGS. 5B and 5C on both the front and back of rear plate 510. The symmetrical constraints of the beams allow for piston wobble, which can increase and decrease the load in an equal and opposite manner from one beam to the other, essentially averaging the strains so that there is a stable bridge output.
  • In the embodiment of FIGS. 4A through 5C, the servo controlling fluid flow rate and volume of fluid delivered can be generally separate in operation from a safety (pressure) monitoring system. The servo controls only the flow rate of the fluid and the volume of the fluid delivered. Unlike the embodiment of FIGS. 1 through 3C, there is no motor current feedback control loop within the servo control. Fluid flow rate and volume are directly related to the velocity and position of the drive member, respectively, and can be controlled, for example, through feedback of position as illustrated in FIGS. 4A and 4B. [0101]
  • As illustrated in FIG. 4C a pressure hazard limit is preferably set at a level to prevent, for example, failure (or bursting) of any component of the fluid path or disposable set. Once the pressure hazard limit is reached, as determined by the pressure monitoring system, an injection procedure is preferably ceased, for example, by preventing current from reaching the motor. In one embodiment, a non-mechanical drive inhibitor is provided that inhibits or disables drive circuits that that are in operative connection with power transducers that act as current amplifiers to power the motor. The drive inhibitor generally performs the functions of the mechanical safe relay discussed in connection with FIGS. 1 through 3C in this embodiment. In general, mechanical embodiments of safe relays are expensive and include magnetic components the can malfunction and/or create artifacts in magnetic resonance environments. [0102]
  • A pressure that is lower than the pressure hazard limit is preferably chosen/identified at which the injector system becomes power limited. For example, current delivered to the motor can be clamped via a current clamp as described above once the power limit pressure is measured. With data/feedback from a real time force sensor or pressure transducer available to the injector system, it is not necessary to preset the power limit before the injection begins (as done in the embodiment of FIGS. 1A through 3C). The power limit can, for example, be activated in real time during an injection procedure by monitoring the force sensor or transducer and setting the power limit (for example, by setting maximum motor current) when the measured force reaches a value corresponding to the power limiting pressure. [0103]
  • FIG. 4B illustrates another embodiment of an injector system of the present invention in which a servo controller controls only fluid flow rate and volume via position feedback as described above. In general, the servo controller sends a signal to a commutator that, in turn, transmits timed signals to a current amplifier including a plurality of level shifters (L/S) or power transducer. In general, the commutator energizes the level shifters in sequence, each for a specific amount of time. The amount of time each level shifter is energized controls the motor power. Separate from the servo controller, a safety (pressure) monitoring system monitors the fluid pressure via a force sensor as described above. In this embodiment, if the safety monitoring system detects that the power limiting pressure has been reached, a signal is sent to the commutator that sets a power clamp as described above by limiting the amount of time the level shifters are energized. If the safety monitoring system detects that the hazard pressure limit has been reached, a signal is sent to the current amplifier that disables the level shifters, thereby stopping the injection procedure. In such an embodiment of the present invention, the servo controller and the safety monitoring system act independently. The safety monitoring system can be viewed as a safety or pressure override system in that the settings programmed into the servo controller by the system operator can be overridden by the safety monitoring system upon the measurement of the power limiting pressure or the pressure hazard limit. [0104]
  • Setting the power limit during operation of the injector eliminates variances caused by temperature and equipment wear, and essentially recalibrates the system during every injection, allowing even more accurate setting of the power limit point. Periodic pressure measurement recalibration can, for example, be performed by measuring force when the system is in a known state (for example, it is known that a syringe is not attached). The system can determine the difference between the measured force and the force that is reasonably expected to be measured when the system is in the known state, and can recalibrate the force sensing system accordingly. [0105]
  • Because the system is effectively recalibrated during every power-limited injection, the injector also has the capability to “learn” from past trends. For example, software algorithms, as known in the computer arts, can use information recorded in memory to learn the behavior of the system and adjust for expected performance changes based on those trends. Calibration changes can, for example, be predicted. [0106]
  • In the injector systems of FIGS. 4A and 4B, the pressure monitoring system determines if the power limiting pressure has been reached and the current/power is clamped at that point. The improved pressure measurement in the embodiment of FIGS. 4A and 4B as compared to deriving fluid pressure from motor current results in a narrowed power limited operating range. As discussed above, the more direct measurement of pressure greatly reduces or eliminates the uncertainty resulting from tolerances of the injector system. [0107]
  • Although sensing pressure via a force transducer on mechanical members of the drive train is superior to the use of motor current, tolerances in the system remain (the largest of which is plunger friction against the syringe barrel) that cause operation to vary within the power limiting performance range illustrated in FIG. 4B. In general, for the injector system to provide the required performance, the lower pressure limit of that range preferably allows sufficient power to deliver fluid per the specifications of the system. There is also a practical constraint on the upper pressure limit of the range in that it should not reach the pressure hazard limit level. If the upper limit of the power limited range overlaps the pressure hazard limit, the injector system can periodically shut down under normal operating conditions and inconvenience the user. A gap between the upper limit of the power limited range and the pressure hazard limit assists in preventing such nuisance shutdowns. The greater tolerances involved in using motor current to measure pressure render it difficult to achieve the proper balance without setting the pressure hazard limit level to an undesirably high level. [0108]
  • To determine an appropriate power limited range, a system simulation model which modeled components of variation within the system was used. In several studies, a Monte Carlo analysis yielded power requirements for each of several planned injection fluids (contrast agents), for each of several planned disposable fluid paths setups. The resulting values were used to establish a nominal power required for each disposable setup, defined as the Power Limit Target. Based on the variation in the components of the system, such as syringe diameter variation, contrast fluid viscosity variation, etc., a figure for uncertainty was calculated. This uncertainty figure, or sigma, was used as a measure of the distribution (nominal 3 sigma, based on a normal distribution) of expected system performance about the Power Limit Target. This resulted in a family of power limit ranges which can, for example, be software selected for the appropriate disposable setup. The disposable components of a disposable set can, for example, include a syringe and the fluid path (for example, connecting tubing etc.) between the syringe and the patient as described above. [0109]
  • The pressure monitoring systems of FIGS. 4A through 5B also facilitate adjustment of the pressure hazard limit and/or the power limiting pressure by the operator of the injector system. Preferably, however, the pressure hazard limit and the power limiting pressure are related (for example, mathematically coupled in software) such that a sufficient gap is maintained between the pressure hazard limit and the power limiting pressure to substantially reduce the likelihood of nuisance shutdowns of the injector system. [0110]
  • In general, the injector systems of FIGS. 4A through 5C control fluid flow until a power limit pressure is measured. The injector systems maintain the delivered fluid flow rate to an operator-programmed value, providing the required pressure as needed based, for example, on the disposable set in place. Once the power limit pressure is measured (for example, for a defined period of time), the system clamps the power delivered to the motor at that point and delivers whatever flow rate is possible at that power limit. If the flow rate achieved is significantly below the programmed value (for example, less than or equal to 10% of the programmed flow rate as averaged over 3 minutes in the ml/min range or as averaged over 3 seconds in the ml/s range), the injection is preferably terminated and the injector disarmed (a stall condition). If for some reason the power limit fails and the measured pressure exceeds a pressure hazard limit (for example, for a defined period of time), fluid delivery is preferably stopped and the injector disarmed. [0111]
  • Thus, the injector systems, as a first priority, deliver the volume of fluid programmed by the operator. As a second priority, the flow rate programmed by the operator is achieved, as long as the measured fluid pressure developed within the injector system is less than the power limiting pressure. The injection is ceased when the programmed volume of fluid has been delivered. If, for any reason, the programmed flow rate is not achieved, the time of the injection is extended to deliver the programmed volume. Under proper operation of the injector system, the power generated by the injector is reduced by the system to keep the operation safe at an internal pressure lower than the pressure hazard limit. The effect of such power limiting is to limit the flow rate that can be achieved with a given disposable set and injection fluid. [0112]
  • In addition to concerns over control of injector systems, it is important to maximize the ease of use of an injector system. In general, current injectors include a housing that encompasses the control and drive mechanisms for the injector. The housing typically also includes a syringe interface to which a syringe can be connected. Such injector housings are often connected to a mobile stand to facilitated positioning of the injector housing. Many such injector housings are also made to be rotatable about an axis to, for example, further facilitate positioning. Moreover, rotation of the injector housing also enables a syringe connected thereto to be directed upwards to expel air from the syringe (by advancing the syringe plunger in a forward direction). Moreover, rotating the syringe downward during an injection procedure minimizes the risk of injecting air. Although current injector systems do provide some mobility as described above, this mobility is quite limited. [0113]
  • In another aspect of the present invention, at least one syringe interface module is made to be separately movable from the remainder of the injector system. The syringe interface module includes one or more syringe interfaces on a housing thereof for connecting one or more syringes thereto. The syringe interface module also includes at least one drive member (for example, piston) housed therein that is adapted to pressurize fluid within the syringe. The syringe interface module can also include a drive mechanism such as a motor to supply power to the drive member. The drive mechanism can also be remote from the syringe interface module, but in operative connection with the drive member. For example, an electric motor can be connected to the drive member remotely via a flexible shaft. Suitable flexible shafts are disclosed, for example, in U.S. Pat. No. 5,494,036, the disclosure of which is incorporated herein by reference. The separately movable syringe module of the present invention greatly improves the ease of use of the injector systems of the present invention by, for example, expanding the locations/positions in which the injector system can be used. [0114]
  • In the embodiment of FIGS. 6A through 6C, for example, an [0115] injector system 200 includes an injector having a control unit 210, a syringe interface module 220 and a syringe 300. Syringe interface module 220 includes an interface 222 for connecting syringe 300 thereto. Syringe interface module 220 also houses a powered drive member or piston that controls movement of a syringe plunger 310 (see FIG. 5A). Syringe interface module 220 also houses a motor (see FIGS. 5A) in operative connection with the piston. The motor is in communicative connection with control circuitry housed in control unit 210 to supply the motor with control signals as known in the art. Current can also be supplied to the motor via control unit 210. However, syringe injection module 220 can also include an independent power source such as a battery (not shown). Preferably, a portable injector stand 400 supports control unit 210 of injector system 200. Injector system 200 can also include a remote control panel 240 that is in communication with control unit 210. Control switches 212 are preferably used to program control parameters for an injection procedure. Some or all of control switches 212 can be duplicated on remote control panel 240. A number of switches 224 can also be provided on syringe interface module 220 to manually control motion of the drive member (for example, forward, reverse, stop etc.).
  • FIG. 6D illustrates an embodiment of a system for carrying out a medical imaging procedure including an [0116] imaging apparatus 260 having an input device 262 (for example, a keyboard). The system preferably further includes one or more attachment members 270 for attaching and/or holding remote control panel 240 in the vicinity the imaging apparatus so that an operator can more readily operate both the imaging apparatus and the injector generally simultaneously.
  • [0117] Syringe interface module 220 is rotatable relative to control unit 210 about an axis A. Because syringe interface module 220 is rotatable relative to control unit 210, syringe loading and multiple injection positions are facilitated while providing the operator with easy and consistent access to control switches 212 of control unit 210. The use of injector system 200 in different positions/locations is also facilitated.
  • FIG. 6B illustrates [0118] syringe interface module 220 in an upright position in both a front view and a side view. After injection fluid is aspirated into syringe 300 by retracting plunger 310, air is preferably expelled while syringe interface module 220 is in an upright position. After air is expelled from syringe 300, syringe interface module 220 is rotated downward as illustrated in FIG. 6A (front view) and 6C (side view) for injection. FIG. 6C illustrates an example of a range of injection positions for syringe interface module 220.
  • FIG. 7 illustrates an embodiment of the present invention in which an [0119] injector system 200 a includes two syringe interface modules 220 a and 220 a′ to which syringes 300 a and 300 a′, respectively, are attached. Each of syringe interface modules 220 a and 220 a′ are rotatably attached to control unit 210 a about an axis A. In FIG. 7, syringe interface module 220 a is rotated downward, while syringe interface module 220 a′ is rotate upward. FIG. 8 illustrates an embodiment in which an injector system 200 b includes a syringe interface module 220 b that includes two syringe interfaces 222 b and 222 b′ to which syringes 300 b and 300 b′, respectively, are connected. Syringe interface module 220 b is rotatably connected to control unit 210 b. Syringe interface module 220 b preferably includes two drive members (not shown) housed therein for independent control of fluid injection from each of syringes 300 b and 300 b′.
  • FIG. 9 illustrates an embodiment of an [0120] injector system 200 c including a syringe interface module 220 c (with attached syringe 300 c) that is physically disconnected from control unit 210 c, but is in communicative connection with control unit 210 c. In the embodiment of FIG. 9, syringe interface module 220 c is in communicative connection with control unit 210 c via communication line 350 c, but the communication between control unit 210 c and syringe interface module 220 c can be wireless using wireless communication protocols as well known in the arts. In the embodiment of FIG. 9, syringe interface module 220 c can be placed in virtually any position and/or orientation regardless of the position and/or orientation of control unit 210 c. For example, the relatively small size and increased mobility (as compared to current injectors) of syringe interface module 220 c enable syringe interface module 220 c to be lain next to a patient.
  • Although the present invention has been described in detail in connection with the above embodiments and/or examples, it is to be understood that such detail is solely for that purpose and that variations can be made by those skilled in the art without departing from the invention. The scope of the invention is indicated by the following claims rather than by the foregoing description. All changes and variations which come within the meaning and range of equivalency of the claims are to be embraced within their scope. [0121]

Claims (42)

What is claimed is:
1. A fluid delivery system comprising:
a control unit comprising one or more devices for controlling a fluid injection;
a syringe comprising a body and a plunger movably disposed within the body; and
at least one syringe interface module separate from but in communication with the control unit, the at least one syringe interface module comprising a module housing, a syringe interface on the module housing that is adapted to connect the syringe to the module housing, and a drive member operable to advance the plunger of the syringe.
2. The fluid delivery system of claim 1, further comprising a motor disposed within the module housing and operably connected to the drive member.
3. The fluid delivery system of claim 2, further comprising a power source operably connected to the motor.
4. The fluid delivery system of claim 1, further comprising a support device for supporting the at least one syringe interface module.
5. The fluid delivery system of claim 1, further comprising a remote control in communication with the control unit.
6. The fluid delivery system of claim 5 wherein the remote control comprises one or more devices for controlling the fluid injection.
7. The fluid delivery system of claim 1 wherein the at least one syringe interface module further comprises one or more devices for controlling the drive member.
8. The fluid delivery system of claim 1 wherein the at least one syringe interface module is in communication with the control unit via a communication line.
9. The fluid delivery system of claim 1 wherein the at least one syringe interface module is in communication with the control unit via a wireless connection.
10. The fluid delivery system of claim 1 wherein the at least one syringe interface module comprises two syringe interface modules.
11. The fluid delivery system of claim 1 wherein the at least one syringe interface module is adapted to be lain next to a patient.
12. The fluid delivery system of claim 1 wherein the at least one syringe interface module is adapted to be placed in any suitable position or orientation regardless of the position or orientation of the control unit.
13. The fluid delivery system of claim 1 wherein the control unit comprises a control unit housing and control circuitry disposed within the control unit housing.
14. The fluid delivery system of claim 13, further comprising a motor disposed within the module housing, operably connected to the drive member and in communication with the control circuitry.
15. The fluid delivery system of claim 14, further comprising a power source operably connected to the motor.
16. The fluid delivery system of claim 15 wherein the control circuitry supplies control signals to the motor.
17. The fluid delivery system of claim 16 wherein the power source comprises a battery.
18. The fluid delivery system of claim 1 wherein the one or more devices on the control unit comprises one or more switches.
19. A fluid delivery system comprising:
a control unit comprising control circuitry and one or more devices for controlling a fluid injection;
a syringe comprising a body and a plunger movably disposed within the body;
at least one syringe interface module separate from but in communication with the control unit via a communication line, the at least one syringe interface module comprising a module housing, a syringe interface on the module housing that is adapted to connect the syringe to the module housing, a drive member operable to advance the plunger of the syringe, and one or more devices for controlling the drive member; and
a support device for supporting the at least one syringe interface module.
20. The fluid delivery system of claim 19, further comprising a motor disposed within the module housing and operably connected to the drive member.
21. The fluid delivery system of claim 20, further comprising a power source operably connected to the motor.
22. The fluid delivery system of claim 19, further comprising a remote control in communication with the control unit.
23. The fluid delivery system of claim 22 wherein the remote control comprises one or more devices for controlling the fluid injection.
24. The fluid delivery system of claim 19 wherein the at least one syringe interface module comprises two syringe interface modules.
25. The fluid delivery system of claim 19 wherein the at least one syringe interface module is adapted to be lain next to a patient.
26. The fluid delivery system of claim 19 wherein the at least one syringe interface module is adapted to be placed in any suitable position or orientation regardless of the position or orientation of the control unit.
27. The fluid delivery system of claim 19, further comprising a motor disposed within the module housing, operably connected to the drive member and in communication with the control circuitry.
28. The fluid delivery system of claim 27, further comprising a power source operably connected to the motor.
29. The fluid delivery system of claim 27 wherein the control circuitry supplies control signals to the motor.
30. The fluid delivery system of claim 19 wherein the one or more devices on the control unit comprises one or more switches.
31. A fluid delivery system comprising:
a control unit comprising control circuitry and one or more devices for controlling a fluid injection;
a syringe comprising a body and a plunger movably disposed within the body;
at least one syringe interface module separate from but in communication with the control unit via a communication line, the at least one syringe interface module comprising a module housing, a syringe interface on the module housing that is adapted to connect the syringe to the module housing, a drive member operable to advance the plunger of the syringe, and one or more devices for controlling the drive member;
a support device for supporting the at least one syringe interface module;
a motor operably connected to the drive member; and
a power source operably connected to the motor.
32. The fluid delivery system of claim 31 wherein the motor is disposed within module housing and is in communication with the control circuitry.
33. The fluid delivery system of claim 31 wherein the motor is operably connected to the drive member via a flexible shaft.
34. The fluid delivery system of claim 31, further comprising a remote control in communication with the control unit.
35. The fluid delivery system of claim 31 wherein the at least one syringe interface module comprises two syringe interface modules.
36. The fluid delivery system of claim 31 wherein the at least one syringe interface module is adapted to be lain next to a patient.
37. The fluid delivery system of claim 31 wherein the at least one syringe interface module is adapted to be placed in any suitable position or orientation regardless of the position or orientation of the control unit.
38. The fluid delivery system of claim 31 wherein the one or more devices on the control unit comprises one or more switches.
39. The fluid delivery system of claim 31 wherein the power source is a battery.
40. The fluid delivery system of claim 1 wherein the at least one syringe interface module is physically separate from the control unit.
41. The fluid delivery system of claim 19 wherein the at least one syringe interface module is physically separate from the control unit.
42. The fluid delivery system of claim 31 wherein the at least one syringe interface module is physically separate from the control unit.
US10/619,265 1999-11-24 2003-07-14 Fluid delivery system having a syringe interface module separate from but in communicaiton with a control unit Abandoned US20040015124A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/619,265 US20040015124A1 (en) 1999-11-24 2003-07-14 Fluid delivery system having a syringe interface module separate from but in communicaiton with a control unit

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16730999P 1999-11-24 1999-11-24
US09/721,427 US6673033B1 (en) 1999-11-24 2000-11-22 Injectors, injector systems and injector control
US10/619,265 US20040015124A1 (en) 1999-11-24 2003-07-14 Fluid delivery system having a syringe interface module separate from but in communicaiton with a control unit

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/721,427 Division US6673033B1 (en) 1999-11-24 2000-11-22 Injectors, injector systems and injector control

Publications (1)

Publication Number Publication Date
US20040015124A1 true US20040015124A1 (en) 2004-01-22

Family

ID=26863039

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/721,427 Expired - Lifetime US6673033B1 (en) 1999-11-24 2000-11-22 Injectors, injector systems and injector control
US10/619,265 Abandoned US20040015124A1 (en) 1999-11-24 2003-07-14 Fluid delivery system having a syringe interface module separate from but in communicaiton with a control unit

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/721,427 Expired - Lifetime US6673033B1 (en) 1999-11-24 2000-11-22 Injectors, injector systems and injector control

Country Status (1)

Country Link
US (2) US6673033B1 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050038390A1 (en) * 2002-08-02 2005-02-17 Mallinckrodt Inc. Injector
US20050224405A1 (en) * 2004-04-13 2005-10-13 Gambro Lundia Ab Connector for a fluid line in an extracorporeal circuit
US20050234382A1 (en) * 2004-04-20 2005-10-20 Gambro Lundia Ab Infusion device for medical fluids
US20070149926A1 (en) * 1998-10-29 2007-06-28 Medtronic Minimed, Inc. Method and Apparatus for Detecting Errors, Fluid Pressure, and Occlusions in an Ambulatory Infusion Pump
CH701270A1 (en) * 2009-06-10 2010-12-15 Tecpharma Licensing Ag Okklusionsüberwachung in an administration unit.
US8454560B2 (en) 2006-12-05 2013-06-04 Mallinckrodt Llc Syringe mount for a medical fluid injector
US20160030663A1 (en) * 2013-03-15 2016-02-04 Concert Medical, Llc Method and system for controllably administering fluid to a patient and/or for controllably withdrawing fluid from the patient
WO2018156707A1 (en) * 2017-02-23 2018-08-30 The Trustees Of Princeton University System and method for monitoring injection site pressure
WO2021101930A1 (en) * 2019-11-21 2021-05-27 Bayer Healthcare Llc System and method for configurable pressure limiting behaviour for fluid injection devices

Families Citing this family (169)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030028145A1 (en) * 1995-04-20 2003-02-06 Duchon Douglas J. Angiographic injector system with multiple processor redundancy
US6656157B1 (en) * 1995-04-20 2003-12-02 Acist Medical Systems, Inc. Infinitely refillable syringe
US6099502A (en) * 1995-04-20 2000-08-08 Acist Medical Systems, Inc. Dual port syringe
US8082018B2 (en) * 1995-04-20 2011-12-20 Acist Medical Systems, Inc. System and method for multiple injection procedures on heart vessels
US7267666B1 (en) * 1995-04-20 2007-09-11 Acist Medical Systems, Inc. Angiographic injector system with multiple processor redundancy
ATE420682T1 (en) * 1997-11-07 2009-01-15 Acist Medical Sys Inc ANGIOGRAPHY SYRINGE WITH MULTIPLE REDUNDANT PROCESSORS
US6669679B1 (en) 2000-01-07 2003-12-30 Acist Medical Systems, Inc. Anti-recoil catheter
US6652489B2 (en) 2000-02-07 2003-11-25 Medrad, Inc. Front-loading medical injector and syringes, syringe interfaces, syringe adapters and syringe plungers for use therewith
US6626862B1 (en) * 2000-04-04 2003-09-30 Acist Medical Systems, Inc. Fluid management and component detection system
US6673048B1 (en) * 2000-05-24 2004-01-06 Acist Medical Systems, Inc. Pressure sleeve assembly
US6663602B2 (en) * 2000-06-16 2003-12-16 Novo Nordisk A/S Injection device
CA2717387C (en) * 2000-07-20 2013-05-21 Acist Medical Systems, Inc. Syringe plunger locking mechanism
US8909325B2 (en) * 2000-08-21 2014-12-09 Biosensors International Group, Ltd. Radioactive emission detector equipped with a position tracking system and utilization thereof with medical systems and in medical procedures
US8565860B2 (en) * 2000-08-21 2013-10-22 Biosensors International Group, Ltd. Radioactive emission detector equipped with a position tracking system
US8489176B1 (en) 2000-08-21 2013-07-16 Spectrum Dynamics Llc Radioactive emission detector equipped with a position tracking system and utilization thereof with medical systems and in medical procedures
US7047058B1 (en) 2001-02-06 2006-05-16 Medrad, Inc. Apparatuses, systems and methods for extravasation detection
AU2002240386A1 (en) * 2001-02-14 2002-08-28 Acist Medical Systems, Inc. Catheter fluid control system
US7566320B2 (en) * 2001-02-14 2009-07-28 Acist Medical Systems, Inc. Fluid injector system
US7308300B2 (en) * 2001-05-30 2007-12-11 Acist Medical Systems, Inc. Medical injection system
MXPA04005514A (en) * 2001-12-07 2005-04-19 Acist Medical Sys Inc Low pressure measurement devices in high pressure environments.
US6821013B2 (en) * 2001-12-20 2004-11-23 Medrad, Inc. Adapters, adapter systems and method for use in connection with powered injectors for agitation of multi-component fluids
US6880808B2 (en) 2002-05-03 2005-04-19 Acist Medical Systems, Inc. Gamma-stable high pressure stopcock
JP4286019B2 (en) * 2003-02-04 2009-06-24 株式会社根本杏林堂 Chemical injection system
EP1596905A2 (en) * 2003-02-21 2005-11-23 Smith and Nephew, Inc. Spinal fluid introduction
US9123077B2 (en) 2003-10-07 2015-09-01 Hospira, Inc. Medication management system
US8065161B2 (en) 2003-11-13 2011-11-22 Hospira, Inc. System for maintaining drug information and communicating with medication delivery devices
US8586932B2 (en) 2004-11-09 2013-11-19 Spectrum Dynamics Llc System and method for radioactive emission measurement
WO2006051531A2 (en) 2004-11-09 2006-05-18 Spectrum Dynamics Llc Radioimaging
US8571881B2 (en) 2004-11-09 2013-10-29 Spectrum Dynamics, Llc Radiopharmaceutical dispensing, administration, and imaging
CN1981210A (en) * 2004-01-13 2007-06-13 光谱动力学有限责任公司 Multi-dimensional image reconstruction
US7968851B2 (en) 2004-01-13 2011-06-28 Spectrum Dynamics Llc Dynamic spect camera
US9470801B2 (en) * 2004-01-13 2016-10-18 Spectrum Dynamics Llc Gating with anatomically varying durations
WO2008010227A2 (en) * 2006-07-19 2008-01-24 Spectrum Dynamics Llc Imaging protocols
EP1750583B1 (en) * 2004-02-11 2014-07-16 ACIST Medical Systems, Inc. System for operating a medical injector and diagnostic imaging device
US8452380B2 (en) * 2004-04-22 2013-05-28 Acist Medical Systems, Inc. Interface device and protocol
EP1778957A4 (en) 2004-06-01 2015-12-23 Biosensors Int Group Ltd Radioactive-emission-measurement optimization to specific body structures
US8900187B2 (en) * 2004-10-13 2014-12-02 Mallinckrodt Llc Powerhead control in a power injection system
US7507221B2 (en) 2004-10-13 2009-03-24 Mallinckrodt Inc. Powerhead of a power injection system
US20060079842A1 (en) * 2004-10-13 2006-04-13 Liebel-Flarsheim Company Powerhead control in a power injection system
JP4698677B2 (en) 2004-10-21 2011-06-08 ノボ・ノルデイスク・エー/エス Dial-down mechanism of roll-up pen type drug delivery device
US8423125B2 (en) 2004-11-09 2013-04-16 Spectrum Dynamics Llc Radioimaging
US9943274B2 (en) 2004-11-09 2018-04-17 Spectrum Dynamics Medical Limited Radioimaging using low dose isotope
US9316743B2 (en) 2004-11-09 2016-04-19 Biosensors International Group, Ltd. System and method for radioactive emission measurement
US8615405B2 (en) 2004-11-09 2013-12-24 Biosensors International Group, Ltd. Imaging system customization using data from radiopharmaceutical-associated data carrier
JP2008520287A (en) 2004-11-16 2008-06-19 メドラッド インコーポレーテッド System and method for determining patient transfer function for drug infusion and modeling patient response
JP5232473B2 (en) 2004-11-24 2013-07-10 メドラッド インコーポレーテッド System and apparatus for modeling the pressure generated during an injection process
US7833189B2 (en) 2005-02-11 2010-11-16 Massachusetts Institute Of Technology Controlled needle-free transport
US20100185152A1 (en) * 2005-02-14 2010-07-22 Novo Nordisk A/S Dosing Operation In A Medical Device
WO2006089547A1 (en) * 2005-02-23 2006-08-31 Novo Nordisk A/S Method and apparatus for reversing a piston rod in an injection device
CN101163514B (en) * 2005-04-24 2012-01-25 诺和诺德公司 Injection device
US8644910B2 (en) * 2005-07-19 2014-02-04 Biosensors International Group, Ltd. Imaging protocols
US8837793B2 (en) 2005-07-19 2014-09-16 Biosensors International Group, Ltd. Reconstruction stabilizer and active vision
US8182444B2 (en) * 2005-11-04 2012-05-22 Medrad, Inc. Delivery of agents such as cells to tissue
US7713232B2 (en) * 2005-11-04 2010-05-11 Medrad, Inc. System for washing and processing of cells for delivery thereof to tissue
US8758294B2 (en) * 2005-12-27 2014-06-24 Acist Medical Systems, Inc. Balloon inflation device
JP5062768B2 (en) * 2006-03-10 2012-10-31 ノボ・ノルデイスク・エー/エス INJECTION DEVICE AND METHOD FOR REPLACING CARTRIDGE OF THE DEVICE
EP1996260B1 (en) * 2006-03-10 2015-09-23 Novo Nordisk A/S An injection device having a gearing arrangement
US8894974B2 (en) 2006-05-11 2014-11-25 Spectrum Dynamics Llc Radiopharmaceuticals for diagnosis and therapy
DE602007004972D1 (en) * 2006-05-16 2010-04-08 Novo Nordisk As GEARING MECHANISM FOR AN INJECTION DEVICE
EP2374488B1 (en) * 2006-05-18 2018-03-21 Novo Nordisk A/S An injection device with mode locking means
EP2040622A2 (en) * 2006-07-17 2009-04-01 Medrad, Inc. Integrated medical imaging systems
RU2453343C2 (en) * 2006-09-29 2012-06-20 Ново Нордиск А/С Injection device with electronic dosimeter
US20080091466A1 (en) 2006-10-16 2008-04-17 Hospira, Inc. System and method for comparing and utilizing activity information and configuration information from multiple device management systems
US8610075B2 (en) 2006-11-13 2013-12-17 Biosensors International Group Ltd. Radioimaging applications of and novel formulations of teboroxime
US9275451B2 (en) 2006-12-20 2016-03-01 Biosensors International Group, Ltd. Method, a system, and an apparatus for using and processing multidimensional data
DK2097835T3 (en) 2006-12-29 2018-09-03 Bayer Healthcare Llc PATIENT-BASED PARAMETER GENERATION SYSTEMS FOR MEDICAL INJECTION PROCEDURES
US20080166292A1 (en) * 2007-01-01 2008-07-10 Medrad, Inc. Pharmaceutical Dosing Method
US8353878B2 (en) * 2007-03-23 2013-01-15 Novo Nordisk A/S Injection device comprising a locking nut
US9333293B2 (en) * 2007-05-09 2016-05-10 Acist Medical Systems, Inc. Injector device, method, and computer program product for detecting a vacuum within a syringe
JP5437240B2 (en) * 2007-07-17 2014-03-12 メドラッド インコーポレーテッド Apparatus, system and method for determining parameters of cardiopulmonary function evaluation and fluid delivery procedures
EP2190506B1 (en) * 2007-08-17 2011-08-17 Novo Nordisk A/S Medical device with value sensor
US9345836B2 (en) 2007-10-02 2016-05-24 Medimop Medical Projects Ltd. Disengagement resistant telescoping assembly and unidirectional method of assembly for such
WO2009044401A2 (en) 2007-10-02 2009-04-09 Yossi Gross External drug pump
US9656019B2 (en) 2007-10-02 2017-05-23 Medimop Medical Projects Ltd. Apparatuses for securing components of a drug delivery system during transport and methods of using same
US10420880B2 (en) 2007-10-02 2019-09-24 West Pharma. Services IL, Ltd. Key for securing components of a drug delivery system during assembly and/or transport and methods of using same
US7967795B1 (en) 2010-01-19 2011-06-28 Lamodel Ltd. Cartridge interface assembly with driving plunger
US8521253B2 (en) * 2007-10-29 2013-08-27 Spectrum Dynamics Llc Prostate imaging
DK2229201T3 (en) * 2007-12-31 2012-07-09 Novo Nordisk As Electronically monitored injection device
WO2009091851A2 (en) * 2008-01-18 2009-07-23 Mallinckrodt Inc. Medical fluid injector with auto-calibration based on system wear and usage
US8608484B2 (en) 2008-03-04 2013-12-17 Medrad, Inc. Dynamic anthropomorphic cardiovascular phantom
US8315449B2 (en) 2008-06-24 2012-11-20 Medrad, Inc. Identification of regions of interest and extraction of time value curves in imaging procedures
CA2735126A1 (en) * 2008-08-26 2010-03-11 Mallinckrodt Inc. Power injector having calibrated pressure monitoring functionality
US9393369B2 (en) 2008-09-15 2016-07-19 Medimop Medical Projects Ltd. Stabilized pen injector
BRPI0919919A2 (en) 2008-10-21 2017-05-30 Massachusetts Gen Hospital cell transplant
US9421330B2 (en) 2008-11-03 2016-08-23 Bayer Healthcare Llc Mitigation of contrast-induced nephropathy
US7922692B2 (en) * 2008-11-04 2011-04-12 Raymond K. Francis Vein scope and injection system
US8271106B2 (en) 2009-04-17 2012-09-18 Hospira, Inc. System and method for configuring a rule set for medical event management and responses
US8338788B2 (en) 2009-07-29 2012-12-25 Spectrum Dynamics Llc Method and system of optimized volumetric imaging
EP3284494A1 (en) 2009-07-30 2018-02-21 Tandem Diabetes Care, Inc. Portable infusion pump system
US8758271B2 (en) 2009-09-01 2014-06-24 Massachusetts Institute Of Technology Nonlinear system identification techniques and devices for discovering dynamic and static tissue properties
US10071198B2 (en) 2012-11-02 2018-09-11 West Pharma. Servicees IL, Ltd. Adhesive structure for medical device
US10071196B2 (en) 2012-05-15 2018-09-11 West Pharma. Services IL, Ltd. Method for selectively powering a battery-operated drug-delivery device and device therefor
US8157769B2 (en) 2009-09-15 2012-04-17 Medimop Medical Projects Ltd. Cartridge insertion assembly for drug delivery system
KR101798671B1 (en) 2009-11-27 2017-11-16 바이엘 인텔렉쳐 프로퍼티 게엠베하 Injector system
WO2011084511A1 (en) 2009-12-15 2011-07-14 Massachusetts Institute Of Technology Jet injector use in oral evaluation
US8348898B2 (en) 2010-01-19 2013-01-08 Medimop Medical Projects Ltd. Automatic needle for drug pump
US9452261B2 (en) 2010-05-10 2016-09-27 Medimop Medical Projects Ltd. Low volume accurate injector
CN106110518A (en) 2010-06-04 2016-11-16 拜耳医药保健有限责任公司 The system and method that multiple dose radiopharmaceutical in radiopharmaceutical syringe uses for planning and monitoring
CA2803169C (en) 2010-06-24 2020-09-22 Medrad, Inc. Modeling of pharmaceutical propagation and parameter generation for injection protocols
CN103153376B (en) * 2010-08-06 2018-04-20 通用医院公司以麻省总医院名义经营 System and apparatus for cell processing related applications
EP2915552A1 (en) * 2010-10-07 2015-09-09 Massachusetts Institute of Technology Injection methods using a servo-controlled needle-free injector
US20120204997A1 (en) * 2011-02-15 2012-08-16 Acist Medical Systems, Inc. Monitoring injector operation
USD702834S1 (en) 2011-03-22 2014-04-15 Medimop Medical Projects Ltd. Cartridge for use in injection device
US11234608B2 (en) 2011-09-02 2022-02-01 Battelle Memorial Institute Extravasation and infiltration detection device with fluid guide provided on a substrate of the detection device to adjust fluid rate based on detection signal
BR112014006869A2 (en) 2011-09-21 2017-04-04 Bayer Medical Care Inc continuous fluid pump device, drive and actuation system and method
US9594875B2 (en) 2011-10-21 2017-03-14 Hospira, Inc. Medical device update system
US9375531B2 (en) 2011-10-27 2016-06-28 Zyno Medical, Llc Syringe pump with improved flow monitoring
DE102011085503B4 (en) * 2011-10-31 2015-04-09 Siemens Aktiengesellschaft Control unit and medical examination device
CA2861706A1 (en) 2011-12-29 2013-07-04 Novo Nordisk A/S Dial-up/dial-down mechanism for wind-up pen
US10335545B2 (en) 2012-01-31 2019-07-02 West Pharma. Services IL, Ltd. Time dependent drug delivery apparatus
WO2013126318A1 (en) * 2012-02-22 2013-08-29 Mallinckrodt Llc Injector system
US9072827B2 (en) 2012-03-26 2015-07-07 Medimop Medical Projects Ltd. Fail safe point protector for needle safety flap
US9463280B2 (en) 2012-03-26 2016-10-11 Medimop Medical Projects Ltd. Motion activated septum puncturing drug delivery device
US10668213B2 (en) 2012-03-26 2020-06-02 West Pharma. Services IL, Ltd. Motion activated mechanisms for a drug delivery device
CN104428660A (en) 2012-05-14 2015-03-18 拜耳医疗保健公司 Systems and methods for determination of pharmaceutical fluid injection protocols based on x-ray tube voltage
US9180242B2 (en) 2012-05-17 2015-11-10 Tandem Diabetes Care, Inc. Methods and devices for multiple fluid transfer
US9421323B2 (en) 2013-01-03 2016-08-23 Medimop Medical Projects Ltd. Door and doorstop for portable one use drug delivery apparatus
EP2964079B1 (en) 2013-03-06 2022-02-16 ICU Medical, Inc. Medical device communication method
US9555379B2 (en) 2013-03-13 2017-01-31 Bayer Healthcare Llc Fluid path set with turbulent mixing chamber, backflow compensator
US9173998B2 (en) 2013-03-14 2015-11-03 Tandem Diabetes Care, Inc. System and method for detecting occlusions in an infusion pump
US20140276569A1 (en) 2013-03-15 2014-09-18 Tandem Diabetes Care, Inc. System and method for detecting presence of an infusion cartridge in an infusion pump
CN116370745A (en) * 2013-04-11 2023-07-04 株式会社根本杏林堂 Medical fluid injection device, medical fluid injection system, syringe, and switch unit
US9011164B2 (en) 2013-04-30 2015-04-21 Medimop Medical Projects Ltd. Clip contact for easy installation of printed circuit board PCB
US9889256B2 (en) 2013-05-03 2018-02-13 Medimop Medical Projects Ltd. Sensing a status of an infuser based on sensing motor control and power input
US20150066531A1 (en) 2013-08-30 2015-03-05 James D. Jacobson System and method of monitoring and managing a remote infusion regimen
US9662436B2 (en) 2013-09-20 2017-05-30 Icu Medical, Inc. Fail-safe drug infusion therapy system
US10311972B2 (en) 2013-11-11 2019-06-04 Icu Medical, Inc. Medical device system performance index
JP2016537175A (en) 2013-11-19 2016-12-01 ホスピーラ インコーポレイテッド Infusion pump automation system and method
DE102013113387A1 (en) 2013-12-03 2015-06-03 Ulrich Gmbh & Co. Kg Injector for injecting a fluid and method for controlling an injector
DE202013105496U1 (en) 2013-12-03 2015-03-05 Ulrich Gmbh & Co. Kg Injector for injecting a fluid
CA2945647C (en) 2014-04-30 2023-08-08 Hospira, Inc. Patient care system with conditional alarm forwarding
US9724470B2 (en) 2014-06-16 2017-08-08 Icu Medical, Inc. System for monitoring and delivering medication to a patient and method of using the same to minimize the risks associated with automated therapy
US10478315B2 (en) * 2014-06-24 2019-11-19 The University Of Toledo Apparatus and method for injecting bone graft substitute and other materials
US9539383B2 (en) 2014-09-15 2017-01-10 Hospira, Inc. System and method that matches delayed infusion auto-programs with manually entered infusion programs and analyzes differences therein
CA3207200A1 (en) 2015-01-09 2016-07-14 Bayer Healthcare Llc Multiple fluid delivery system with multi-use disposable set and features thereof
US9795534B2 (en) 2015-03-04 2017-10-24 Medimop Medical Projects Ltd. Compliant coupling assembly for cartridge coupling of a drug delivery device
US10251813B2 (en) 2015-03-04 2019-04-09 West Pharma. Services IL, Ltd. Flexibly mounted cartridge alignment collar for drug delivery device
US9744297B2 (en) 2015-04-10 2017-08-29 Medimop Medical Projects Ltd. Needle cannula position as an input to operational control of an injection device
US10293120B2 (en) 2015-04-10 2019-05-21 West Pharma. Services IL, Ltd. Redundant injection device status indication
EP3304370B1 (en) 2015-05-26 2020-12-30 ICU Medical, Inc. Infusion pump system and method with multiple drug library editor source capability
US10149943B2 (en) 2015-05-29 2018-12-11 West Pharma. Services IL, Ltd. Linear rotation stabilizer for a telescoping syringe stopper driverdriving assembly
US10576207B2 (en) 2015-10-09 2020-03-03 West Pharma. Services IL, Ltd. Angled syringe patch injector
US9987432B2 (en) 2015-09-22 2018-06-05 West Pharma. Services IL, Ltd. Rotation resistant friction adapter for plunger driver of drug delivery device
CN108430536B (en) 2015-10-09 2022-04-08 西医药服务以色列分公司 Method of filling a custom syringe
US9724473B2 (en) * 2016-01-12 2017-08-08 Nickolas Peter Demas Multi-directional low-displacement force sensor
CN111544704B (en) 2016-01-21 2022-06-03 西医药服务以色列有限公司 Force containment in autoinjectors
WO2017127215A1 (en) 2016-01-21 2017-07-27 Medimop Medical Projects Ltd. Needle insertion and retraction mechanism
JP6885960B2 (en) 2016-01-21 2021-06-16 ウェスト ファーマ サービシーズ イスラエル リミテッド Drug delivery device with visual indicators
WO2017152036A1 (en) 2016-03-03 2017-09-08 Bayer Healthcare Llc System and method for improved fluid delivery in multi-fluid injector systems
WO2017161076A1 (en) 2016-03-16 2017-09-21 Medimop Medical Projects Ltd. Staged telescopic screw assembly having different visual indicators
JP6957525B2 (en) 2016-06-02 2021-11-02 ウェスト ファーマ サービシーズ イスラエル リミテッド Needle evacuation by 3 positions
AU2017295722B2 (en) 2016-07-14 2022-08-11 Icu Medical, Inc. Multi-communication path selection and security system for a medical device
EP3490635B1 (en) 2016-08-01 2021-11-17 West Pharma. Services Il, Ltd. Partial door closure prevention spring
JP6869327B2 (en) 2016-08-01 2021-05-12 ウェスト ファーマ サービシーズ イスラエル リミテッド Anti-rotation cartridge
CN110869072B (en) 2017-05-30 2021-12-10 西部制药服务有限公司(以色列) Modular drive mechanism for a wearable injector
AU2018326485B2 (en) 2017-08-31 2024-01-04 Bayer Healthcare Llc Injector pressure calibration system and method
CA3066780A1 (en) 2017-08-31 2019-03-07 Bayer Healthcare Llc Fluid injector system volume compensation system and method
JP7252143B2 (en) * 2017-08-31 2023-04-04 バイエル・ヘルスケア・エルエルシー System and method for mechanical calibration of drive member position and fluid injector system
EP3675929A1 (en) 2017-08-31 2020-07-08 Bayer Healthcare LLC Method for dynamic pressure control in a fluid injector system
WO2019046299A1 (en) 2017-08-31 2019-03-07 Bayer Healthcare Llc Fluid path impedance assessment for improving fluid delivery performance
JP7402799B2 (en) 2017-12-22 2023-12-21 ウェスト ファーマ サービシーズ イスラエル リミテッド Syringes available with different cartridge sizes
AU2019306490A1 (en) 2018-07-17 2021-02-04 Icu Medical, Inc. Updating infusion pump drug libraries and operational software in a networked environment
US10861592B2 (en) 2018-07-17 2020-12-08 Icu Medical, Inc. Reducing infusion pump network congestion by staggering updates
WO2020018389A1 (en) 2018-07-17 2020-01-23 Icu Medical, Inc. Systems and methods for facilitating clinical messaging in a network environment
US11483403B2 (en) 2018-07-17 2022-10-25 Icu Medical, Inc. Maintaining clinical messaging during network instability
US10692595B2 (en) 2018-07-26 2020-06-23 Icu Medical, Inc. Drug library dynamic version management
CA3107315C (en) 2018-07-26 2023-01-03 Icu Medical, Inc. Drug library management system
DE102022107119A1 (en) 2022-03-25 2023-09-28 Ulrich Gmbh & Co. Kg Control device for a peristaltic pump, peristaltic pump, injection device and method for controlling a peristaltic pump
DE202022101585U1 (en) 2022-03-25 2023-06-28 Ulrich GmbH & Co. KG Control device and control system for a peristaltic pump, peristaltic pump with such a control device and injection device with such a peristaltic pump

Citations (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2925814A (en) * 1956-10-30 1960-02-23 Foster L Vibber Transfusion apparatus
US3623474A (en) * 1966-07-25 1971-11-30 Medrad Inc Angiographic injection equipment
US3631847A (en) * 1966-03-04 1972-01-04 James C Hobbs Method and apparatus for injecting fluid into the vascular system
US3701345A (en) * 1970-09-29 1972-10-31 Medrad Inc Angiographic injector equipment
US3812843A (en) * 1973-03-12 1974-05-28 Lear Siegler Inc Method and apparatus for injecting contrast media into the vascular system
US3880138A (en) * 1973-03-12 1975-04-29 Lear Siegler Inc Method for injecting contrast media into the vascular system
US4006736A (en) * 1974-11-27 1977-02-08 Medrad, Inc. Angiographic injector
US4024864A (en) * 1975-09-05 1977-05-24 Cordis Corporation Injector with overspeed protector
US4392847A (en) * 1979-01-08 1983-07-12 Whitney Douglass G Injection and monitoring system
US4465473A (en) * 1981-11-24 1984-08-14 Contraves Ag Injection apparatus for the dosed delivery of a liquid
US4494051A (en) * 1982-03-05 1985-01-15 The Garrett Corporation Multi-quadrant brushless DC motor drive
US4677980A (en) * 1984-06-06 1987-07-07 Medrad, Inc. Angiographic injector and angiographic syringe for use therewith
US4812724A (en) * 1984-11-13 1989-03-14 Liebel-Flarsheim Corporation Injector control
US4854324A (en) * 1984-01-31 1989-08-08 Medrad, Inc. Processor-controlled angiographic injector device
US5300031A (en) * 1991-06-07 1994-04-05 Liebel-Flarsheim Company Apparatus for injecting fluid into animals and disposable front loadable syringe therefor
US5354273A (en) * 1992-12-14 1994-10-11 Mallinckrodt Medical, Inc. Delivery apparatus with pressure controlled delivery
US5383858A (en) * 1992-08-17 1995-01-24 Medrad, Inc. Front-loading medical injector and syringe for use therewith
US5494036A (en) * 1993-11-26 1996-02-27 Medrad, Inc. Patient infusion system for use with MRI
US5681285A (en) * 1992-10-15 1997-10-28 Baxter International Inc. Infusion pump with an electronically loadable drug library and a user interface for loading the library
US5803712A (en) * 1988-05-17 1998-09-08 Patient Solutions, Inc. Method of measuring an occlusion in an infusion device with disposable elements
US5808203A (en) * 1997-05-12 1998-09-15 Medrad, Inc. Fluid pressure measurement devices
US5868710A (en) * 1996-11-22 1999-02-09 Liebel Flarsheim Company Medical fluid injector
US6225904B1 (en) * 1999-09-29 2001-05-01 Refrigerator Manufacturers, Inc. Automatic sliding door system for refrigerator unit
US6262544B1 (en) * 2000-02-28 2001-07-17 Delphi Technologies, Inc. Four quadrant motor operation using DC bus current sensing

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1000159B (en) 1989-06-15 1991-10-10 Micrel Kentro Efarm Mikroilekt Syringe pump

Patent Citations (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2925814A (en) * 1956-10-30 1960-02-23 Foster L Vibber Transfusion apparatus
US3631847A (en) * 1966-03-04 1972-01-04 James C Hobbs Method and apparatus for injecting fluid into the vascular system
US3623474A (en) * 1966-07-25 1971-11-30 Medrad Inc Angiographic injection equipment
US3701345A (en) * 1970-09-29 1972-10-31 Medrad Inc Angiographic injector equipment
US3812843A (en) * 1973-03-12 1974-05-28 Lear Siegler Inc Method and apparatus for injecting contrast media into the vascular system
US3880138A (en) * 1973-03-12 1975-04-29 Lear Siegler Inc Method for injecting contrast media into the vascular system
US4006736A (en) * 1974-11-27 1977-02-08 Medrad, Inc. Angiographic injector
US4024864A (en) * 1975-09-05 1977-05-24 Cordis Corporation Injector with overspeed protector
US4392847A (en) * 1979-01-08 1983-07-12 Whitney Douglass G Injection and monitoring system
US4465473A (en) * 1981-11-24 1984-08-14 Contraves Ag Injection apparatus for the dosed delivery of a liquid
US4494051A (en) * 1982-03-05 1985-01-15 The Garrett Corporation Multi-quadrant brushless DC motor drive
US4854324A (en) * 1984-01-31 1989-08-08 Medrad, Inc. Processor-controlled angiographic injector device
US4677980A (en) * 1984-06-06 1987-07-07 Medrad, Inc. Angiographic injector and angiographic syringe for use therewith
US4812724A (en) * 1984-11-13 1989-03-14 Liebel-Flarsheim Corporation Injector control
US5803712A (en) * 1988-05-17 1998-09-08 Patient Solutions, Inc. Method of measuring an occlusion in an infusion device with disposable elements
US5300031A (en) * 1991-06-07 1994-04-05 Liebel-Flarsheim Company Apparatus for injecting fluid into animals and disposable front loadable syringe therefor
US5383858A (en) * 1992-08-17 1995-01-24 Medrad, Inc. Front-loading medical injector and syringe for use therewith
US5383858B1 (en) * 1992-08-17 1996-10-29 Medrad Inc Front-loading medical injector and syringe for use therewith
US5681285A (en) * 1992-10-15 1997-10-28 Baxter International Inc. Infusion pump with an electronically loadable drug library and a user interface for loading the library
US5354273A (en) * 1992-12-14 1994-10-11 Mallinckrodt Medical, Inc. Delivery apparatus with pressure controlled delivery
US5494036A (en) * 1993-11-26 1996-02-27 Medrad, Inc. Patient infusion system for use with MRI
US5868710A (en) * 1996-11-22 1999-02-09 Liebel Flarsheim Company Medical fluid injector
US5808203A (en) * 1997-05-12 1998-09-15 Medrad, Inc. Fluid pressure measurement devices
US6225904B1 (en) * 1999-09-29 2001-05-01 Refrigerator Manufacturers, Inc. Automatic sliding door system for refrigerator unit
US6262544B1 (en) * 2000-02-28 2001-07-17 Delphi Technologies, Inc. Four quadrant motor operation using DC bus current sensing

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070149926A1 (en) * 1998-10-29 2007-06-28 Medtronic Minimed, Inc. Method and Apparatus for Detecting Errors, Fluid Pressure, and Occlusions in an Ambulatory Infusion Pump
US8715237B2 (en) * 1998-10-29 2014-05-06 Medtronic Minimed, Inc. Method and apparatus for detecting errors, fluid pressure, and occlusions in an ambulatory infusion pump
US20110119033A1 (en) * 1998-10-29 2011-05-19 Medtronic Minimed, Inc. Method and Apparatus for Detecting Errors, Fluid Pressure, and Occlusions in an Ambulatory Infusion Pump
US7892206B2 (en) * 1998-10-29 2011-02-22 Medtronic Minimed, Inc. Method and apparatus for detecting errors, fluid pressure, and occlusions in an ambulatory infusion pump
US20070250005A1 (en) * 2002-08-02 2007-10-25 Mallinckrodt Inc. Injector
US20050038389A1 (en) * 2002-08-02 2005-02-17 Mallinckrodt Inc. Injector
US20050038390A1 (en) * 2002-08-02 2005-02-17 Mallinckrodt Inc. Injector
US8882704B2 (en) 2002-08-02 2014-11-11 Mallinckrodt Llc Injector
US7854726B2 (en) * 2002-08-02 2010-12-21 Liebel-Flarsheim Company Injector
US20050038386A1 (en) * 2002-08-02 2005-02-17 Mallinckrodt Inc. Injector
US20050224405A1 (en) * 2004-04-13 2005-10-13 Gambro Lundia Ab Connector for a fluid line in an extracorporeal circuit
US8858485B2 (en) 2004-04-13 2014-10-14 Gambro Lundia Ab Connector for a fluid line in an extracorporeal circuit
US7517332B2 (en) 2004-04-20 2009-04-14 Gambro Lundia Ab Infusion device for medical fluids
US20050234382A1 (en) * 2004-04-20 2005-10-20 Gambro Lundia Ab Infusion device for medical fluids
US9248241B2 (en) 2006-12-05 2016-02-02 Liebel-Flarsheim Company Llc Syringe mount for a medical fluid injector
US8454560B2 (en) 2006-12-05 2013-06-04 Mallinckrodt Llc Syringe mount for a medical fluid injector
WO2010142048A1 (en) * 2009-06-10 2010-12-16 Tecpharma Licensing Ag Occlusion monitoring in an administering device
CH701270A1 (en) * 2009-06-10 2010-12-15 Tecpharma Licensing Ag Okklusionsüberwachung in an administration unit.
US20160030663A1 (en) * 2013-03-15 2016-02-04 Concert Medical, Llc Method and system for controllably administering fluid to a patient and/or for controllably withdrawing fluid from the patient
US10420882B2 (en) * 2013-03-15 2019-09-24 Medovate Limited Method and system for controllably administering fluid to a patient and/or for controllably withdrawing fluid from the patient
US11712515B2 (en) * 2013-03-15 2023-08-01 Medovate Limited Method and system for controllably administering fluid to a patient and/or for controllably withdrawing fluid from the patient
WO2018156707A1 (en) * 2017-02-23 2018-08-30 The Trustees Of Princeton University System and method for monitoring injection site pressure
US11351313B2 (en) 2017-02-23 2022-06-07 The Trustees Of Princeton University System and method for monitoring injection site pressure
WO2021101930A1 (en) * 2019-11-21 2021-05-27 Bayer Healthcare Llc System and method for configurable pressure limiting behaviour for fluid injection devices

Also Published As

Publication number Publication date
US6673033B1 (en) 2004-01-06

Similar Documents

Publication Publication Date Title
US6673033B1 (en) Injectors, injector systems and injector control
US6520930B2 (en) Injectors, injector systems and injector control
US6659980B2 (en) Methods, apparatuses, and uses for infusion pump fluid pressure and force detection
WO2001037904A2 (en) Injectors, injector systems and injector control
US20050177111A1 (en) Miniature infusion pump
US9943680B2 (en) Systems and method for assessing functionality of dual check valve arrangements in medical tubing sets
EP0192786B1 (en) Processor-controlled angiographic injector device
EP2190516B1 (en) High precision infusion pump controller
US20040133166A1 (en) Methods, apparatuses, and uses for infusion pump fluid pressure and force detection
CN113750319B (en) Integrated closed-loop artificial pancreas with multiple infusion modes
AU2018326380B2 (en) System and method for drive member position and fluid injector system mechanical calibration
JP2003511104A (en) Device for administering injectable drugs
JP2009148591A (en) Injection pump and its usage of the same
US20200368437A1 (en) Needle-Free Transdermal Injection Device
WO2010027636A1 (en) Medical fluid injector calibration apparatus
US11598664B2 (en) Injector pressure calibration system and method
JPH0656311B2 (en) Device and method for obtaining a desired weight of material
JP6104538B2 (en) Injection device and method for determining injection pressure
WO2002064095A3 (en) Method and system for delivering contrast agent

Legal Events

Date Code Title Description
AS Assignment

Owner name: MEDRAD, INC., PENNSYLVANIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SCIULLI, FRANICS J.;GRIFFITHS, DAVID M.;NOLAN, WILLIAM J., JR.;AND OTHERS;REEL/FRAME:014308/0152;SIGNING DATES FROM 20010502 TO 20010504

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION